<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">106822</article-id>
<article-id pub-id-type="doi">10.7554/eLife.106822</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.106822.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Cell Biology</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Microbiology and Infectious Disease</subject>
</subj-group>
</article-categories><title-group>
<article-title>Dissecting organoid-bacteria interaction highlights decreased contractile force as a key factor for heart infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6616-2828</contrib-id>
<name>
<surname>Wang</surname>
<given-names>Anheng</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Jiaxian</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Zhe</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Chuan</given-names>
</name>
<xref ref-type="aff" rid="a9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Deng</surname>
<given-names>Chunhao</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0921-8244</contrib-id>
<name>
<surname>Chen</surname>
<given-names>Guokai</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Chengwu</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Qian</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a8">8</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2013-4191</contrib-id>
<name>
<surname>Dong</surname>
<given-names>Lei</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a7">7</xref>
<email>leidong@nju.edu.cn</email>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Chunming</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a5">5</xref>
<xref ref-type="aff" rid="a6">6</xref>
<email>CMWang@umac.mo</email>
</contrib>
<aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01r4q9n85</institution-id><institution>Institute of Chinese Medical Sciences &amp; State Key Laboratory of Quality Research in Chinese Medicine, University of Macau</institution></institution-wrap>, <city>Macau</city>, <country country="CN">China</country></aff>
<aff id="a2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01rxvg760</institution-id><institution>School of Life Sciences &amp; State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University</institution></institution-wrap>, <city>Nanjing</city>, <country country="CN">China</country></aff>
<aff id="a3"><label>3</label><institution>HELP Therapeutics, Nanjing</institution>, <city>Jiangsu</city>, <country country="CN">China</country></aff>
<aff id="a4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01r4q9n85</institution-id><institution>Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau</institution></institution-wrap>, <city>Macau</city>, <country country="CN">China</country></aff>
<aff id="a5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01r4q9n85</institution-id><institution>Department of Pharmaceutical Sciences, Faculty of Health Sciences, University of Macau</institution></institution-wrap>, <city>Macau</city>, <country country="CN">China</country></aff>
<aff id="a6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01r4q9n85</institution-id><institution>Zhuhai UM Science and Technology Research Institute, University of Macau</institution></institution-wrap>, <city>Hengqin</city>, <country country="CN">China</country></aff>
<aff id="a7"><label>7</label><institution>National Resource Center for Mutant Mice</institution>, <city>Nanjing</city>, <country country="CN">China</country></aff>
<aff id="a8"><label>8</label><institution>Chinese Intractable Disease IPS Cell Model Library (CBiPS)</institution>, <city>Nanjing</city>, <country country="CN">China</country></aff>
<aff id="a9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01t001k65</institution-id><institution>School of Mechanical Engineering, Chongqing Jiaotong University</institution></institution-wrap>, <city>Chongqing</city>, <country country="CN">China</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Gurkar</surname>
<given-names>Aditi U</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of Pittsburgh</institution>
</institution-wrap>
<city>Pittsburgh</city>
<country country="US">United States</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Ajijola</surname>
<given-names>Olujimi A</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>University of California, Los Angeles</institution>
</institution-wrap>
<city>Los Angeles</city>
<country country="US">United States</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="coi-statement"><p>Competing interests: No competing interests declared</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2025-09-10">
<day>10</day>
<month>09</month>
<year>2025</year>
</pub-date>
<volume>14</volume>
<elocation-id>RP106822</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2025-04-08">
<day>08</day>
<month>04</month>
<year>2025</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2025-04-14">
<day>14</day>
<month>04</month>
<year>2025</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2025.04.08.647814"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2025, Wang et al</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Wang et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-106822-v1.pdf"/>
<abstract>
<title>Abstract</title><p>Bacterial endocarditis is a fatal cardiovascular disease exacerbated by weakened heart contraction, yet the direct impact of cardiac contractility on bacterial adhesion remains elusive. Here, we present a novel quantitative physics model integrating finite element analysis and live-cell imaging to uncover their strong correlation. Using this model, we quantified the real-time force magnitude generated by organoid-type cardiac microtissue derived from healthy donors and dilated cardiomyopathy patients – mimicking normal and suppressed heart contractility, respectively – to the approaching bacteria in a real fluidic system. The data revealed that weakened cardiac contractility facilitated bacterial invasion of the myocardium. Verifying this finding in a mouse transverse aortic constriction model demonstrated that increasing heart contraction efficiently mitigated bacterial invasion, with a 25% increase in heart contractility reducing endocarditis risk by 80%. Our findings demonstrate that patient-derived cardiac organoids provide a physiologically relevant platform for studying bacterial infections in vitro, offering high clinical fidelity. This platform establishes a valuable tool for drug screening and the development of novel therapeutic strategies.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>Patient-derived cells</kwd>
<kwd>Cardiac organoid</kwd>
<kwd>Bacterial endocarditis</kwd>
<kwd>Fluid modelling</kwd>
<kwd>Organoid-bacteria interactions</kwd>
<kwd>Image analysis</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>

</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Infective endocarditis (IE) poses significant challenges to global health, affecting 1.5 million patients annually with an over 40% mortality rate[<xref ref-type="bibr" rid="c1a">1a</xref>]. A substantial cause of IE is a bacterial infection, but how the heart becomes prone to the infection remains a fundamental question[<xref ref-type="bibr" rid="c1b">1b</xref>, <xref ref-type="bibr" rid="c2">2</xref>]. Decades of clinical evidence reveal that patients with a history of valvular heart disease, congenital heart disease, previous infective endocarditis, or cardiomyopathy have a significantly greater chance of IE[<xref ref-type="bibr" rid="c3a">3a,b,c</xref>]. All these diseases have the comorbidity of heart failure, as characterized by decreased myocardial contractility[<xref ref-type="bibr" rid="c4a">4a,b,c</xref>]. Bacteria must adhere to tissue surfaces for infection[<xref ref-type="bibr" rid="c5a">5a,b</xref>], and its adhesion is dictated by the status of the surface[<xref ref-type="bibr" rid="c6">6</xref>] (e.g. dynamic[<xref ref-type="bibr" rid="c7a">7</xref>] or static[<xref ref-type="bibr" rid="c8">8</xref>]) and the physical environment (e.g. fluidic stress[<xref ref-type="bibr" rid="c9">9</xref>]). However, it remains unknown how the heart tissue – under dynamic, repeated, intrinsically driven contractions – influences bacterial adhesion. We hypothesized that decreased myocardial contractility facilitates bacterial infection – which is typically resisted by the robust contractile force in a healthy heart.</p>
<p>Verifying this hypothesis requires a quantitative analysis of the dynamic interactions between the contracting myocardium and moving bacteria, which is challenging for two reasons. The first is the lack of an <italic>in vitro</italic> three-dimensional (3D) cardiac model recapitulating the weakened contractility, as it is unfeasible to adjust the contractility in patients and perform real-time sampling of bacteria-infected hearts <italic>in vivo</italic>. Although organoids have emerged as a powerful 3D tool to mimic various human tissue[<xref ref-type="bibr" rid="c10">10</xref>] and organs[<xref ref-type="bibr" rid="c11">11</xref>],[<xref ref-type="bibr" rid="c12">12</xref>], – including cardiac organoids (COs) of varying extents of maturity[<xref ref-type="bibr" rid="c13a">13a,b,c</xref>], they are made of healthy myocardial or progenitor cells and do not exhibit pathologically weakened contractility[<xref ref-type="bibr" rid="c11">11</xref>]. The second challenge lies in quantifying bacteria-organoid interaction where COs keep generating intrinsic contractions[<xref ref-type="bibr" rid="c14">14</xref>]. Previous analyses have examined regional variations in the contractility of cardiomyocytes[<xref ref-type="bibr" rid="c15a">15a.b</xref>]. However, it remains challenging to ascertain the physical environment and contractile forces of individual cardiac organoids solely through image recognition techniques. To accurately reconstruct the fluid field of COs and quantify the magnitude of forces exerted by COs on bacteria, a more realistic and sophisticated system is required. Such a system would enable the transformation of motion data into meaningful force measurements, providing deeper insights into the mechanical interactions between COs and their microenvironment.</p>
<p>To overcome these challenges, we aimed to develop an engineering model that integrates human clinical samples with new quantitative tools to dissect how myocardial contractility influences bacterial infection of the myocardium. We first constructed two types of clinically relevant COs through the direct assembly of three cell components into cavity-containing microtissues. Each microtissue comprises human induced pluripotent stem cells (hiPSCs) derived from either patients with dilated cardiomyopathy[<xref ref-type="bibr" rid="c16">16</xref>] (DCM) or healthy donors, assembled with both stromal and endothelial cells. These COs were co-cultured with two representative pathogens commonly inducing IE[<xref ref-type="bibr" rid="c17">17</xref>]. Distinct from the conventional high-risk IE patients, DCM patients do not exhibit structural cardiac abnormalities similar to congenital heart disease[<xref ref-type="bibr" rid="c18">18</xref>], but frequently present with heart failure[<xref ref-type="bibr" rid="c19">19</xref>]. These properties make DCM well-suited for investigating whether pure heart failure alone can influence the outcomes of bacterial infections. Both organoids exhibited the dynamic diastole-systole cycle, and the former recapitulated the weakened motility – a key feature of DCM observed clinically. To analyze the interactions in this dynamic setting between planktonic bacteria and beating COs[<xref ref-type="bibr" rid="c20a">20a,b</xref>], we created a series of quantitative models by applying finite element modelling (FEM)[<xref ref-type="bibr" rid="c21">21</xref>] for dynamic live-cell image analysis, which highlighted mechanical features of COs in the fluidic system[<xref ref-type="bibr" rid="c22">22</xref>]. Surprisingly, the data revealed a strong inverse correlation between cardiac contractility and bacterial adherence to myocardial tissue. As the contractile force of the cardiomyocyte increased, the number of bacteria adhering to the heart muscle significantly decreased (<xref rid="fig1" ref-type="fig">Fig. 1</xref>). This effect was consistent across multiple bacterial strains tested. This groundbreaking discovery opens up new avenues for the development of innovative therapeutic strategies to combat cardiac infections. This organoid-based model represents a reliable platform for quantifying the biomechanical forces in bacteria-organoid interactions, thereby opening new avenues for drug discovery and therapeutic innovations.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Schematic of experiments with patient-derived cardiac organoids for bacterial infection study.</title></caption>
<graphic xlink:href="647814v1_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Construction of COs exhibiting pathologically decreased contractility</title>
<p>To construct 3D organoids recapitulating regular and weakened heart contractions, we first generated two clinically relevant CMs in 2D monolayers from hiPSCs derived from DCM patients and healthy individuals – namely DCM-CMs and H-CMs, respectively, following an established protocol[<xref ref-type="bibr" rid="c23">23</xref>] (<xref rid="fig1" ref-type="fig">Fig. 1</xref>). DCM-CMs and H-CMs exhibited different morphologies and Troponin localization (<xref rid="fig2" ref-type="fig">Fig 2A</xref>; staining for troponin on day 33) and had high proportions of cardiomyocytes exceeding 85% (DCM, <xref ref-type="supplementary-material" rid="supp1">Fig. S1A</xref>) and 97% (CM. <xref ref-type="supplementary-material" rid="supp1">Fig. S1B</xref>), respectively. Similar to its corresponding clinical symptoms, DCM showed significantly weaker contractility compared with CM, as evidenced by patch clamp tests (<xref rid="fig2" ref-type="fig">Fig. 2B</xref>), although their beating rates were similar (<xref rid="fig2" ref-type="fig">Fig. 2C</xref>). The DCM cells were derived from a 47-years-old Asian male with an LMNA gene mutation. The LMNA gene primarily encodes lamin A and C, which are nuclear lamina proteins; its mutation can lead to dilated DCM, mainly by impairing cardiac contractile function and causing cardiac conduction block[<xref ref-type="bibr" rid="c24a">24a,b,c</xref>]. Our data indicated that the DCM and CM had distinct transcriptional profiles (<xref ref-type="supplementary-material" rid="supp1">Fig. S1C</xref>; bulk RNA sequencing [RNA-seq] on day 22). Compared with H-CMs, DCM-CMs expressed significantly lower levels of MYH7 (for cardiac cell contraction) and FLNC (for maintaining sarcomere integrity), among other contractility-related genes (e.g. ACTN2, HCN4, TNNI1), and a higher level of PLN (associated with arrhythmogenic in DCM patients[<xref ref-type="bibr" rid="c25">25</xref>]).</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Preparation of human cardiac organoids (COs) of healthy and dilated cardiomyopathy (DCM) characteristics</title><p>(A) Immunohistochemical staining for cardiomyocyte biomarker (Troponin). Scale bars, 100 µm.</p><p>(B) Electrophysiological data of DCM and CM measured using patch clamp.</p><p>(C) Membrane patch-clamp measurements of the potential and heartbeat frequency data in DCM and CM.</p><p>(D) Fluorescence microscope observation of the formation of HCOs with different cell ratios. The ECs were red (Celltracker-far red), and MSC was green (CFSE) in the Fluorescence Observation. The bar is 50µm.</p><p>(E) Fluorescence microscope observation of the formation of DCM-COs with different cell ratios. The ECs were red (Celltracker-far red), and MSC was green (CFSE) in the Fluorescence Observation. The bar is 50µm.</p><p>(F) Confocal Observation of Calponin / α-actinin / MHC / Troponin localisation within the HCOs. The Calponin / MHC were labelled green (Alexaflour 488), and Troponin / α-actinin were labelled red (Alexaflour 647). The bar is 50 µm.</p><p>(G) Immunohistochemical staining for classic endocarditis biomarker (vWF, CD31 and Collagen Type 1) on Mice heart valves section. The vWF waslabelled green (Alexaflour 488), CD31 Collagen Type 1 and was labelled red (Alexaflour 647). Scale bars, 10µm.</p><p>(H) Immunohistochemical staining for classic endocarditis biomarker (vWF, CD31 and Collagen Type 1) on Mice heart ventricle section. The vWF waslabelled green (Alexaflour 488), CD31 Collagen Type 1 and was labelled red (Alexaflour 647). Scale bars, 10µm.</p><p>(I) Immunohistochemical staining for classic endocarditis biomarker (vWF, CD31 and Collagen Type 1) on Cardiac organoids section. The vWF waslabelled green (Alexaflour 488), CD31 Collagen Type 1 and was labelled red (Alexaflour 647). Scale bars, 10µm.</p></caption>
<graphic xlink:href="647814v1_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>We performed cell movement analysis based on over 50 plots using TrackMate (Jean-Yves Tinevez and Jaqaman et al. [<xref ref-type="bibr" rid="c26a">26a,b</xref>]). Both CMs started to develop contractility on day eight at ∼ 50-70 beats per minute (bpm), close to the adult human heart rate of 60-100 bpm (<xref ref-type="supplementary-material" rid="supp1">Fig. S1D</xref>). H-CMs contracted with a constant intensity similar to a healthy heart (<xref ref-type="supplementary-material" rid="video1">Video S1</xref>), while DCM-CMs displayed an irregular frequency and amplitude of exercise with reduced intensity (<xref ref-type="supplementary-material" rid="video2">Video S2</xref>).</p>
<p>Then, we constructed 3D microtissues towards assembly into cavity-containing COs, based on these 2D CMs and DCMs. Physiologically, the endocardium comprises CMs, endothelial cells (ECs), and stromal cells. Co-culturing CMs with both human umbilical vein endothelial cells (HUVECs, representing ECs) and human mesenchymal stem cells (MSCs, representing stromal cells) formed larger, more compact spheroid microtissues than culturing CMs alone or CMs with ECs (<xref ref-type="supplementary-material" rid="supp1">Fig. S1E</xref>). We tested three different proportions for the tri-cellular composition of CM and DCM, respectively (<xref rid="fig2" ref-type="fig">Fig. 2D</xref> and <bold>E</bold>) and found the optimal one for constructing the 3D microtissue was 6:2:2 (CM/DCM: EC: MSC). Under this condition, the spheroidal microtissue aggregated more rapidly and exhibited stronger motility than under others, similar to their actual proportion in the human fetal heart. The addition of MSCs and ECs to CMs increased the expression of cell motility-and structure-related genes (e.g. ACTG1, COL4A2, COL5A3, TIMP12; <xref ref-type="supplementary-material" rid="supp1">Fig. S1F</xref>). However, in MSC/ECs/CMs co-cultured organoids, MLF1 and SCP2 were down-regulated compared to individual CMs culture, which accounts for hematopoietic cell development lipid metabolism, respectively. In this ratio, the ECs formed apparent networks spreading throughout the microtissue after five days of culture (<xref rid="fig2" ref-type="fig">Fig. 2F</xref><bold>, S1G)</bold>, with a live recording of organoid formation in this cellular proportion from Day 1 through Day 3 (Red, ECs; Green, CM; <xref ref-type="supplementary-material" rid="video3">Video S3</xref>).</p>
<p>Next, we examined these microtissues for their characteristics as cavity-containing COs. Indeed, they contained clear cavity structures – as evidenced by morphological observation upon MHC and troponin staining for myosin (<xref rid="fig2" ref-type="fig">Fig. 2F</xref>), which are highly comparable with other studies on the construction and definition of COs[<xref ref-type="bibr" rid="c13a">13a</xref>, <xref ref-type="bibr" rid="c27">27</xref>]. Further examination of the different layers from top to bottom of these COs demonstrated the presence of substantial cavities in the core of these organoids (<xref ref-type="supplementary-material" rid="supp1">Fig. S1G</xref>). Thus, we adopted this condition to prepare DCM-COs and HCOs in subsequent experiments.</p>
<p>Finally, we determined the suitability of these COs as a model for endocardial bacterial infection, by staining for three key targets involved in <italic>Staphylococcus aureus</italic> (<italic>S. A</italic>) infection – vWF, CD31, type 1 collagen[<xref ref-type="bibr" rid="c24b">24</xref>, <xref ref-type="bibr" rid="c24c">24</xref>, <xref ref-type="bibr" rid="c28a">28a,b,c</xref>] – in mouse heart sections and our engineered HCOs in parallel. We noticed a consistent distribution of all three markers between them (mouse heart valves, <xref rid="fig2" ref-type="fig">Fig. 2G</xref>; mouse ventricular endocardium, <xref rid="fig2" ref-type="fig">Fig. 2H</xref>; HCOs, <xref rid="fig2" ref-type="fig">Fig. 2I</xref>). Specifically, CD31 and vWF were primarily distributed on the surface and in a deeper site, respectively, of the tissue, while Type I collagen spread widely.</p>
</sec>
<sec id="s2b">
<title>Characterization of the contractility of the two clinically-derived COs</title>
<p>We examined the contractility of the two CO types by dividing an organoid into multiple regions at 15-μm intervals and using TrackMate<sup>®</sup> to track the precise motion of individual regions (<xref rid="fig3" ref-type="fig">Fig. 3A</xref>). We observed a higher amplitude of contraction in HCOs (<xref ref-type="supplementary-material" rid="video4">Video S4</xref>) than in DCM-COs (<xref ref-type="supplementary-material" rid="video5">Video S5</xref>), specifically including a higher mean speed (<xref rid="fig3" ref-type="fig">Fig. 3B</xref><bold>, S2A)</bold>. Meanwhile, DCM-COs exhibited a clear central motion with weaker motility on the edge, while HCOs’ contraction was relatively uniform (<xref rid="fig3" ref-type="fig">Fig. 3C</xref><bold>, S2B</bold>). Similarly, the straightness of DCM-COs’ motion was lower, as its movement was less forceful or regular (<xref ref-type="supplementary-material" rid="supp1">Fig. S2C</xref>). These findings agreed with the outcome observed in 2D CMs.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>Dissection of COs-bacteria interactions in the contraction-induced fluidic system</title><p>(A) Tracking process of the COs movement. The first step was to check the tracking area, the second was to confirm the partition size, and the third was to select the appropriate threshold for tracking.</p><p>(B) Mean speed for different tracked IDs obtained from HCOs. Each CO was divided into 100-200 15-μm circles.</p><p>(C) Mean displacement heatmap of the HCOs and DCM-COs. Each CO was divided into 100-200 15-μm circles. Tested on two group of 6 independent COs in total (n=6).</p><p>(D) The total displacement produced by the HCOs and DCM-COs in 3 seconds.</p><p>(E) Hotelling’s Test examines the correlation between HCOs and DCM-COs moving in 3 seconds.</p><p>(F) Displacement of HCOs within a single systolic-diastolic cycle for contraction and circulation, respectively. Tested on two groups of 6 independent HCOs in total (n=6).</p><p>(G) Displacement of DCM-COs within a single systolic-diastolic cycle for contraction and circulation, respectively. Tested on two groups of 6 independent DCM-COs in total (n=6).</p><p>(H) Two-dimensional hotelling’s test analysis of motion correlations between HCOs and DCM-COs for systolic and diastolic displacement processes.</p><p>(I) Finite element analysis of the forces exerted by HCOs on a 1-µm<sup>2</sup> water field. The analysed velocities of the acting forces were taken from the maximum and minimum velocities of the HCOs obtained from the tracking procedure.</p><p>(J) Finite element analysis of the forces exerted by DCM-CO on a 1-µm<sup>2</sup> water field. The analysed velocities of the acting forces were taken from the maximum and minimum velocities of the DCM-COs obtained from the tracking procedure.</p></caption>
<graphic xlink:href="647814v1_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>We recorded that the mean displacement of HCOs through two systole-diastole cycles was 2.5 times greater than that of DCM-COs (<xref rid="fig3" ref-type="fig">Fig. 3D</xref>). For each completed motion, we performed Hotelling’s test for three different COs. The within-group range of DCM-COs was more comprehensive, indicating poorer internal consistency. At the same time, the overall motion patterns of HCOs and DCM-COs were similar (<xref rid="fig3" ref-type="fig">Fig. 3E</xref>), with no significant difference (<italic>P</italic>&gt;0.05). However, if the complete motion was divided into systole and diastole processes, HCOs, like a normal heart, exhibited slightly greater contraction than relaxation (<xref rid="fig3" ref-type="fig">Fig. 3F</xref>). In contrast, DCM-COs showed the opposite pattern, with higher relaxation than contraction (<xref rid="fig3" ref-type="fig">Fig. 3G</xref>). The 2D spatial motion tests also indicated that the two segments of motion in DCM-COs were utterly uncorrelated, while HCOs exhibited a considerable degree of correlation (<xref rid="fig3" ref-type="fig">Fig. 3H</xref>), as also recorded by a live-transformed tracking video (<xref ref-type="supplementary-material" rid="video6">Video S6</xref>; red, HCOs; blue, DCM-COs). DCM-COs reproduced the characteristics of the disease – an imbalance between systolic and diastolic blood pressure. HCOs showed a systolic cycle similar to a normal heart, with their systolic pressure greater than diastolic pressure[<xref ref-type="bibr" rid="c26a">26a</xref>, <xref ref-type="bibr" rid="c29a">29a,b</xref>]. Overall, HCOs and DCM-COs replicated the patterns of disease movement in the body, with DCM-COs exhibiting weaker motion characteristics and contraction-release dysregulation.</p>
</sec>
<sec id="s2c">
<title>FEM analysis of CO-bacteria interactions in the contraction-induced fluidic system</title>
<p>The contractile force of DCM exceeds that of relaxation, which may result in bacteria being more likely to approach the edges of COs, potentially facilitating bacterial adhesion. To verify the validity of this hypothesis, we initially constructed a simulated fluidic system to model the behavior of particles near DCM-CO and CM-CO interfaces.
<list list-type="simple">
<list-item><label>i)</label><p>setting appropriate thresholds to acquire parameters (e.g. velocity of motion and average displacement),</p></list-item>
<list-item><label>ii)</label><p>transforming the coupled data of the Fourier series into a sinusoidal motion waveform and inputting the sinusoidal waveform into the fluid system to construct a sphere-like motion and</p></list-item>
<list-item><label>iii)</label><p>using the FEM model to simulate the movement of particles near the sphere (Representing COs) to make an initial inference on the behaviour of bacteria in the vicinity.</p></list-item></list></p>
<p>The region-specific motility (velocity) generated above enabled us to evaluate the force in the fluid-solid system that can affect bacterial adhesion. We employed FEM to analyse how the contracted COs could influence the surrounding fluidic environment and bacterial adhesion in a real, dynamic physical system. The results showed that “points” (referring to the velocity of individual zones tracked by TrackMate<sup>®</sup>) appearing in the high-speed segment (red) were more in HCOs (<xref rid="fig3" ref-type="fig">Fig. 3B</xref>) than in DCM-COs (<xref ref-type="supplementary-material" rid="supp1">Fig. S2A</xref>); over 70% of points fell within the low-speed motion range in the latter. We extracted the data of COs contraction and converted them reversely through Fourier-transformed into motion curves in the Ansys fluent system[<xref ref-type="bibr" rid="c30a">30a,b</xref>].</p>
<p>As illustrated in <xref ref-type="supplementary-material" rid="supp1">Fig. S2D</xref> and <bold>E</bold>, a white circle in the center represents a fit CO derived from TrackMate-generated data of HCOs or DCM-COs. The water around HCOs exhibited a higher flow velocity than that around DCM-COs because of the more muscular contraction of the former. In the FEM system, we “placed” 1-µm-particles of “bacteria” at different distances from the organoid center and employed the ANSYS Fluent software to predict the trajectory of a “bacteria cell” by integrating the force balance on the particle calculated by a Lagrangian reference frame. This force balance equates the particle inertia with the forces applied to the particle, as written below:
<disp-formula>
<graphic xlink:href="647814v1_ueqn1.gif" mimetype="image" mime-subtype="gif"/>
</disp-formula>
Where mp is the particle mass, is the fluid phase velocity, up is the particle velocity, and p is the liquid density. P is the density of the particle, F is an additional force, <inline-formula><inline-graphic xlink:href="647814v1_inline1.gif" mimetype="image" mime-subtype="gif"/></inline-formula> is the drag force, and Tr is the droplet or particle relaxation time calculated by:
<disp-formula>
<graphic xlink:href="647814v1_ueqn2.gif" mimetype="image" mime-subtype="gif"/>
</disp-formula>
Here, μ is the molecular viscosity of the fluid, dp is the particle diameter, and Re is the relative Reynolds number, which is defined as
<disp-formula>
<graphic xlink:href="647814v1_ueqn3.gif" mimetype="image" mime-subtype="gif"/>
</disp-formula>
The “bacteria” at different distances received varying forces, with those closer to the organoid boundary subjected to more excellent propulsion. Since the input mass data, density, and other parameters of bacterial particles and cells are consistent, the primary distinguishing factor for particle motion is the motion data of the COs.The particles around HCOs moved in a similar pattern as the diastole-systole cycle; those almost on the organoid boundary were slightly pulled closer at the end of each cycle, while those at a greater distance almost remained in place. Notably, HCOs (<xref rid="fig3" ref-type="fig">Fig. 3I</xref>) could generate 1.5-time higher maximum force (43.25 µN versus 27.76 µN) and nearly 5-time greater minimum force than did DCM-COs (<xref rid="fig3" ref-type="fig">Fig. 3J</xref>), which should pose a significant impact on the bacteria. However, by measuring the positions of the “bacteria” and COs at the beginning and end of their motion (<xref ref-type="supplementary-material" rid="supp1">Fig. S2F</xref> and <bold>G</bold>), we observed that the contraction and relaxation of COs generated two forces on the bacteria – pushing and pulling – that eventually failed to push the bacteria away from the organoid boundaries. Different motion intensities of HCOs and DCM-COs led to varying influences on the bacteria. HCOs, with regular systolic and diastolic cycles, possessed higher forces and caused stronger absolute displacements of particles – but paradoxically brought bacteria closer. DCM-COs, resulting from abnormal systolic and diastolic cycles, pushed bacteria further away. To solve this contradiction, verifying which factor (final coordinate or mean displacement) ultimately has a greater influence on bacterial adhesion is necessary.</p>
</sec>
<sec id="s2d">
<title>Quantitative elucidation of decreased CO contractility on increased bacterial infection in co-culture</title>
<p>We cultured COs with <italic>S. A</italic>, the most common bacteria species inducing IE clinically. This species cannot move via self-propulsion due to their lack of flagella or cilia [<xref ref-type="bibr" rid="c31">31</xref>] and exhibit Brownian motion. Based on their weak motility, we speculated that they, similar to the particles in the FEM system, could be strongly influenced by the COs. To validate this assumption, we placed these two bacteria near the contracting COs and tracked them for an extended period of 48 hours.</p>
<p>We immediately tracked the movement of <italic>S. A</italic> within 100 μm to the periphery of HCO (<xref ref-type="supplementary-material" rid="supp1">Fig. S2H</xref>) or DCM-CO (<xref ref-type="supplementary-material" rid="supp1">Fig. S2I</xref>) after inoculation. The bacteria around HCO formed an elongated straight line (<xref rid="fig4" ref-type="fig">Fig. 4A</xref>), markedly different from the point-like Brownian motion observed in the control group without COs (<xref ref-type="supplementary-material" rid="video7">Video S7</xref>, <xref rid="fig4" ref-type="fig">Fig. 4C</xref>). The weak motility of DCM-COs possessed a much slighter influence on the movement of bacteria than HCOs did (<xref rid="fig4" ref-type="fig">Fig. 4B</xref>, <xref ref-type="supplementary-material" rid="video8">Video S8</xref>). Upon thorough analysis of a single bacterial movement near HCO (<xref rid="fig4" ref-type="fig">Fig. 4D</xref>) or DCM-CO (<xref rid="fig4" ref-type="fig">Fig. 4E</xref>), it was observed that bacteria experienced stretching and pulling due to the contraction and relaxation of COs, with a synchronized, oscillatory motion. Moreover, the experimental results were highly consistent with the simulations. After completing a cycle of contraction and relaxation of COs, the final position of bacteria indeed tended to be closer to COs, whereas the results around DCM-COs were contrary (<xref rid="fig4" ref-type="fig">Fig. 4D and E</xref>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Dynamic analysis of bacterial infection of cardiac organoids</title><p>(A) Heatmap of the total displacement and track path of <italic>S. A</italic> around HCOs. The bar is 50 μm.</p><p>(B) Heatmap of the total displacement and track path of <italic>S. A</italic> around DCM-COs. The bar is 10 μm.</p><p>(C) Heatmap of <italic>S. A</italic> total displacement and track path of the planktonic <italic>S. A</italic> in the medium. For (A-C), the tracing lasting for two diastolic-systolic cycles was 3 seconds. The bar is 10 μm</p><p>(D) Analysis of the movement routes of <italic>S. A</italic> in the systole-diastolic cycle near the fringe around HCOs. The bar is 10 μm</p><p>(E) Analysis of the movement routes of <italic>S. A</italic> in the systole-diastolic cycle near the fringe around DCM-COs. The bar is 10 μm</p><p>(F) Z-stacked live observation of <italic>S. A</italic> infection after a 24-hour co-culture with HCOs (left) or DCM-COs (right). Red: HUVEC (CellTrace Far-red); blue: CM (Cytotell Blue); Green: <italic>S. A</italic> (CFSE). The bar is 50 μm</p><p>(G) Fluorescence observation of <italic>S. A</italic> infection after a 24-hour co-culture with HCOs (left) or DCM-COs (right). Green: <italic>S. A</italic> (CFSE). The bar is 50 μm</p><p>(H) Fluorescence Observation of the infection outcome of <italic>S. A</italic> infection after 48h co-culture with HCOs and DCM-COs, respectively. Green: <italic>S. A</italic> (CFSE). The bar is 50 μm</p><p>(I) CLSM Observation MHC/DAPI/<italic>S. A</italic> of the infection outcome of <italic>S. A</italic> infection after 24h incubation in the vicinity of HCOs.The bar is 10 μm</p><p>(J) CLSM Observation MHC / DAPI / <italic>S. A</italic> of the infection outcome of <italic>S. A</italic> infection after 24h incubation in the vicinity of DCM-COs.The bar is 10 μm</p><p>(K) Quantification of the bacterial attachment on HCOs and DCM-COs after 24h incubation using fluorescence intensity measurement.</p></caption>
<graphic xlink:href="647814v1_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>After an additional 24 hours, we observed the adhesion of <italic>S. A</italic>. Surprisingly, a magnificent amount of bacteria adhered to DCM-COs after 24 hours of inoculation, whereas very few adhered to HCOs (<xref rid="fig4" ref-type="fig">Fig. 4F, G</xref>). Following an additional 48 hours of co-incubation, both types of COs were noticeably adhered to by <italic>S. A</italic> (<xref rid="fig4" ref-type="fig">Fig. 4H</xref>). We co-localized MHC distribution in <italic>S. A</italic> and COs after 24 hours of co-culturing. The <italic>S. A</italic> adhered to them significantly less compared to DCM-COs (<xref rid="fig4" ref-type="fig">Fig. 4I, J,K</xref>).</p>
<p>These results seemed to contradict our previous simulations and motion analyses, suggesting that the motion of COs does not necessarily make bacteria more susceptible to infection by bringing them closer. Notably, from 24 to 48 hours, the bacteria started adhering to HCOs, accompanied by a markedly decreased motility with these organoids (<xref ref-type="supplementary-material" rid="video9">Video S9</xref>). Also, bacteria disrupted the overall movement of COs, which changed towards local peristalsis 48 h post-infection (<xref ref-type="supplementary-material" rid="video10">Video S10</xref>), indicative of the significantly weakened motility of COs. Based on these results, we speculated that COs’ motility could influence the infection outcomes instead of the diastole-systole imbalance, as HCOs exhibited significantly stronger motility than DCM-COs.</p>
<p>To determine whether the motility of COs can deviate from bacterial adhesion, we run trajectory and motion analysis on the bacteria around the COs. First, we analyzed the overall motion trajectories of CO and nearby <italic>S. A</italic>. We found that both HCO (<xref rid="fig5" ref-type="fig">Fig. 5A</xref>) and DCM-CO (<xref rid="fig5" ref-type="fig">Fig. 5B</xref>) could change the motion pattern of surrounding <italic>S. A</italic> from Brownian motion to more ordered motion. <italic>S. A</italic> at the edge of HCOs was entrained by the movement of HCOs, resulting in an average displacement even 1.5 times greater than that of HCOs themselves (<xref rid="fig5" ref-type="fig">Fig. 5A</xref>), while the displacement near DCM-COs remained the same with that of the HCOs (<xref rid="fig5" ref-type="fig">Fig. 5B</xref>). Overall, the displacement of <italic>S. A</italic> around HCOs was more than twice that around DCM-COs. T Hotelling’s test also indicated that the <italic>S. A</italic> near CM was utterly unrelated to that of planktonic <italic>S. A</italic>, while <italic>S. A</italic> around DCM-COs remained related (<xref rid="fig5" ref-type="fig">Fig. 5C</xref>). Notably, although the motion patterns of the two CO types partially overlapped, those of <italic>S. A</italic> around each CO type were distinct (<xref rid="fig5" ref-type="fig">Fig. 5D</xref>). The reason might be that HCO, representing the healthy tissue, exerted twice as strongly as DCM-COs, reflecting the pathological myocardium, to alter bacterial motility to resist infection.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>Quantifying the influence of force on bacteria adhesion</title><p>(A) Mean displacement of <italic>S. A</italic> near HCOs (HCO-<italic>S. A</italic>) and correlated HCOs compared to planktonic <italic>S. A</italic>.</p><p>(B) Mean displacement of <italic>S. A</italic>-near DCMCOs (DCMCO-<italic>S. A</italic>) and correlated DCMCOs compared to planktonic <italic>S. A</italic>.</p><p>(C) Two-dimensional hotelling’s test analysis of motion correlations between <italic>S. A-near</italic> HCOs (HCO-<italic>S. A</italic>), <italic>S. A</italic> near DCM<italic>-</italic>COs (DCMCO-<italic>S. A</italic>) and planktonic <italic>S. A</italic>.</p><p>(D) Two-dimensional hotelling’s test analysis of motion correlations between <italic>S. A</italic>-near HCOs (<italic>S. A</italic>-CM) and correlated HCOs (HCOs), <italic>S. A</italic> near DCM<italic>-</italic>COs (<italic>S.A</italic>-DCM) and correlated DCM-COs (DCM-COs)</p><p>(E) Quantitative analysis of HCOs contraction strength (total displacement during a systole-diastolic cycle) after treatment with different concentrations of isoproterenol (1 or 50μM).</p><p>(F) The infection status of HCOs organoids after 24-hour co-culture with <italic>S. A</italic> (10<sup>5</sup>/mL) under different 3 treatment groups (PBS as control, 1 or 5 μM isoproterenol as drug) compared to the <italic>S. A</italic> in medium (Blank Control) determined by the Colony forming unit (CFU) method.</p><p>(G) The counting results in the CFU assay obtained from <xref rid="fig5" ref-type="fig">Fig. 5F</xref>.</p></caption>
<graphic xlink:href="647814v1_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Therefore, the contracting COs appeared to inhibit bacterial adhesion by affecting the latter’s movement. To validate this speculation, we employed two additional bacteria species – <italic>Pseudomonas aeruginosa</italic> (<italic>P. A</italic>) and <italic>Streptococcus anginosus</italic> (<italic>S. S</italic>). The former possesses vigorous motility (up to 10 µm/s) because of its robust flagella, parallel with the other two stationary bacteria. The latter performs like <italic>S. A, exhibiting</italic> Brownian Motion. Indeed, <italic>P. A</italic> exhibited significantly stronger motility (<xref ref-type="supplementary-material" rid="supp1">Fig. S3A, B and C</xref>), with a greater mean displacement (<xref ref-type="supplementary-material" rid="supp1">Fig. S3D</xref>) and speed (<xref ref-type="supplementary-material" rid="supp1">Fig. S3E</xref>) during a 3-second tracking period than <italic>S. A</italic> and <italic>S. S</italic>. Consequently, <italic>P. A</italic> demonstrated a double average velocity (<xref ref-type="supplementary-material" rid="supp1">Fig. S3E</xref>) and four-time larger displacement (<xref ref-type="supplementary-material" rid="supp1">Fig. S3F</xref>) and double average velocity than the other two non-motile bacteria. Meanwhile, the motility of <italic>P. A</italic> was hardly affected by COs due to its strong velocity (<xref ref-type="supplementary-material" rid="supp1">Fig. S3G</xref>). The two-dimensional Hotelling test further revealed that HCO-<italic>P. A</italic>, DCM-CO-<italic>P. A</italic>, and <italic>P. A</italic> alone had similar patterns of movements (<xref ref-type="supplementary-material" rid="supp1">Fig. S3H</xref>). Interestingly, neither HCOs nor DCM-COs could remain uninfected after 24-hour co-incubation with <italic>P. A</italic> (<xref ref-type="supplementary-material" rid="supp1">Fig. S3I</xref> and <bold>J</bold>), consistent with this bacteria’s motility characteristics observed above. Besides, like <italic>S. A</italic>, <italic>S. S</italic> infected HCOs lightly (<xref ref-type="supplementary-material" rid="supp1">Fig. S3K</xref>) but DCM-COs severely (<xref ref-type="supplementary-material" rid="supp1">Fig. S3L, M</xref>). These results indicated that the motility of the bacteria and COs collectively determined the infection outcomes.</p>
<p>However, was it because of different surface characteristics – instead of motility – between the two COs that made DCM-COs easier for adhesion? To answer this question, we measured the adhesive forces of the bacteria on different COs by coating the bacteria on AFM probes and cantilever (<xref ref-type="supplementary-material" rid="supp1">Fig. S4A</xref>). Bacteria adhered to cantilevers using poly-L-lysine, and the adhesion forces between COs and <italic>S. A</italic> (<xref ref-type="supplementary-material" rid="supp1">Fig. S4B</xref>), <italic>S. S</italic> (<xref ref-type="supplementary-material" rid="supp1">Fig. S4C</xref>), or <italic>P. A</italic> (<xref ref-type="supplementary-material" rid="supp1">Fig. S4D</xref>) were measured in the probe mode[<xref ref-type="bibr" rid="c32a">32a,b</xref>]. The results indicated that <italic>S. A</italic> exhibited greater adhesive forces on HCOs (&gt; 30 nN) than on DCM-COs (<xref ref-type="supplementary-material" rid="supp1">Fig. S4E</xref>); meanwhile, <italic>P. A</italic> showed a similar adhesion to both COs (<xref ref-type="supplementary-material" rid="supp1">Fig. S4F</xref>). These data excluded varying bacterial adhesion to different CO types as the reason for different infection scenarios. Our findings uncovered the correlation between the infection of COs by planktonic bacteria and the motility of COs themselves.</p>
<p>In addition, we tested whether enhancing cardiomyocyte beating could further reduce infection. We accelerated the contractility of HCOs with Isoproterenol (ISO) [<xref ref-type="bibr" rid="c33a">33a,b</xref>], which, at varying concentrations, significantly enhanced cardiac activity (<xref rid="fig5" ref-type="fig">Fig. 5E</xref>) and thereby inhibited bacterial adhesion. At 5 uM (<xref rid="fig5" ref-type="fig">Fig. 5F</xref>), ISO triggered a nearly fourfold increase in beating capacity that resulted in almost no bacterial attachment to the COs (<xref rid="fig5" ref-type="fig">Fig. 5G</xref>).</p>
</sec>
<sec id="s2e">
<title>Omics analysis revealing <italic>S. A</italic> disrupts CO contraction to facilitate infection</title>
<p>Based on our previous observations, we identified a correlation between bacterial infection and the motility strength of COs. However, after 48 hours of cultivation, both highly and weakly motile COs failed to escape bacterial adhesion. We speculate that this phenomenon may be attributed to the impairment of COs’ motility following co-cultivation of bacteria.</p>
<p>Based on this hypothesis, we observed that the movement of the HCOs after infection was significantly mitigated after 24h inculcation with <italic>S. A</italic> more than two times (<xref rid="fig6" ref-type="fig">Fig. 6A</xref>). Our Hottling’s test result also indicated that The motility of infected COs and HCOs becomes significantly divergent (<xref ref-type="supplementary-material" rid="supp1">Fig. S5A</xref>). Alongside these observations, the cellular activity against bacteria also sharply declines to only 4.543N, over nine times lower than the HCOs (41.86N) (<xref ref-type="supplementary-material" rid="supp1">Fig. S5B</xref>).</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title>Dissecting the influence of toxins on CO contractility and bacterial infection</title><p>(A) Mean displacement of the <italic>S. A</italic> infected HCOs (24-hour inoculation) and the healthy control HCOs, the track length is 3s. n= 6 biologically independent samples (Two groups for HCOs/Infected HCOs each).</p><p>(B) Heat map of DE genes in the metabolic pathway Reactome ECM organisation Pathway (R-HSA-1474244) in the organoid model showing different trends in the changes in gene expression after <italic>S. A</italic> infection compared to healthy organoid control after 24 hours. The colour scale shows the row z score. Organoid samples, n= three biologically independent samples per group (each sample containing one well of 10-20 organoids);</p><p>(C) Heat map of DE genes in the metabolic pathway Reactome Muscle Contraction Pathway (R-HSA-397014) in the organoid model showing different trends in the changes in gene expression after <italic>S. A</italic> infection compared to healthy organoid control after 24 hours. The colour scale shows the row z score. Organoid samples, n= three biologically independent samples per group (each sample containing one well of 10-20 organoids);</p><p>(D) Distribution of protein secretion and fold change; non-DE (yellow) and DE genes (Red for downregulation and blue for up-regulation) of <italic>S. A</italic> isolated from <italic>S. A</italic> HCOs infection model were compared with the control <italic>S. A</italic>.</p><p>(E) Heat map of DE protein secretion in the metabolic pathway KEGG bacterial infection Pathway (H02076) in the organoid model shows different trends in gene expression changes after <italic>S. A</italic> infection compared to healthy organoid control after 48 hours. The colour scale shows the row z score. Organoid samples, n= three biologically independent samples per group (each sample containing one well of 10-20 organoids);</p><p>(F) Immunohistochemical staining for <italic>S. A</italic> infection site on H-COs after 24h incubation. The bar is 10 μm.</p><p>(G) Immunohistochemical staining for <italic>S. A</italic> infection site on HCOs after 24h incubation. The bar is 10 μm.</p><p>(H) Immunohistochemical staining for <italic>S. A</italic> infection site on HCOs after 24h incubation. The bar is 4 μm.</p></caption>
<graphic xlink:href="647814v1_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>On the dynamic COs-bacteria interactions, we sought to understand how bacteria influenced CO contraction to increase adhesion. First, we verified that <italic>S. A</italic> inoculation greatly changed the expression of genes related to tissue structure and motility, such as ECM production and degradation and myocardial contraction (<xref rid="fig6" ref-type="fig">Fig. 6B</xref>, <xref ref-type="supplementary-material" rid="supp1">Table 1</xref>). For example, out of 64 ECM-related proteins, 62 genes in <italic>S. A</italic> infected-HCOs were down-regulated (e.g., COL3A1, COL1A1, MMP9, and MMP19) compared to non-infected ones (<xref rid="fig6" ref-type="fig">Fig. 6B</xref>, <xref ref-type="supplementary-material" rid="supp1">Table 1</xref>). The infection also changed muscle contraction-related genes, such as upregulating MYL2 and CES1 (<xref rid="fig6" ref-type="fig">Fig. 6C</xref>), and genes related to heart contraction, mainly including potassium ion channel protein-related genes (KCNE4 and KCNIP2) [<xref ref-type="bibr" rid="c34a">34a,b</xref>] and smooth muscle alpha-actin (ACTG2)[<xref ref-type="bibr" rid="c35a">35a,b</xref>], were all down-regulated. In <italic>S. A</italic> infection cases, the majority of ECM-related genes (&gt; 90%; <xref rid="fig6" ref-type="fig">Fig. 6B</xref>) and muscle contraction-related ones (&gt; 70%; <xref rid="fig6" ref-type="fig">Fig. 6C</xref>) were down-regulated compared to the healthy endocardium, indicating compromised tissue structure and motility by the bacterial infection.</p>
<p>Thus, we compared the data against the real-world transcriptomic data from human bacterial endocarditis (BE) studies (E-MEXP-1334)[<xref ref-type="bibr" rid="c36">36</xref>]. Notably, the differentially expressed (DE) genes of the COs overlapped with &gt;566 genes (43.7%) of human DE genes (<xref ref-type="supplementary-material" rid="supp1">Fig. S5D</xref>) – which is even higher than the overlap between animal mouse and human models demonstrated by previous research[<xref ref-type="bibr" rid="c10">10</xref>]. Reactome analysis indicated that the overlapped genes included those related to ECM structure (<xref ref-type="supplementary-material" rid="supp1">Fig. S5C, E</xref>). Since ample clinical evidence suggests that bacteria-secreted toxins play key roles in mediating infective endocarditis[<xref ref-type="bibr" rid="c26a">26a</xref>, <xref ref-type="bibr" rid="c37a">37a,b,c</xref>], we investigated the proteomic change of <italic>S. A</italic> during their infection of HCOs, which revealed 701 and 145 significantly up-and down-regulated genes, respectively (<xref rid="fig6" ref-type="fig">Fig. 6D</xref>, <xref ref-type="supplementary-material" rid="supp1">Table 2</xref>). The expression correlation between <italic>S. A</italic> in planktonic status and those infecting HCOs was below 47%, while the inter-group correlation within <italic>S. A</italic> exceeded 97% and that within HCOs-SA exceeded 85% (<xref ref-type="supplementary-material" rid="supp1">Fig. S5F</xref>). Among the top 25 differentially secreted proteins (<xref ref-type="supplementary-material" rid="supp1">Table 2</xref>), exotoxins were the most significantly highly expressed proteins. The main exotoxins involved include leukocidin, fibrinogen-binding protein, and alpha-hemolysin (<xref rid="fig6" ref-type="fig">Fig. 6E</xref>). These toxins were clinically identified as the primary factor driving the pathological processes of <italic>S. A</italic> infection, leading to compromised heart contractions by destroying the cell and ECM structure[<xref ref-type="bibr" rid="c38">38</xref>],[<xref ref-type="bibr" rid="c39">39</xref>],[<xref ref-type="bibr" rid="c40">40</xref>]. The <italic>S. A</italic> could also penetrate inside the COs or DCM-COs after 48-h incubation (<xref rid="fig6" ref-type="fig">Fig. 6F, G, H</xref>)</p>
<p>Then, we inspected the structural changes of the COs after <italic>S. A</italic> infection (<xref rid="fig7" ref-type="fig">Fig. 7A-D</xref>). Indeed, the α-actinin distribution was significantly disrupted and became uneven after infection (<xref rid="fig7" ref-type="fig">Fig. 7C</xref> and <bold>D</bold>), as were MHC and troponin, though the overall integrity of the microtissue remained. These findings again underscored the significant impact of bacterial infection on the proteins related to tissue structure and myocardial contractility in the COs. Quantitative analysis of the images reveals that the structures of actin, calponin, and troponin (<xref rid="fig7" ref-type="fig">Fig. 7E</xref>) were severely disrupted after infection, while MHC (<xref rid="fig7" ref-type="fig">Fig. 7F</xref>) was relatively less affected.</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><title>Bacterial infection reduced COs contraction by influencing myosin structure</title><p>(A) CLSM Observation HCO’s DAPI/ Calponin/ α-actinin localisation. The bar is 50μm.</p><p>(B) CLSM Observation HCO’s DAPI/ MHC/ Troponin localisation. The bar is 50μm.</p><p>(C) CLSM Observation HCO’s DAPI/ Calponin/ α-actinin localisation after infection after 24h co-culture with <italic>S. A</italic>. The bar is 50μm.</p><p>(D) CLSM Observation HCO’s DAPI/ MHC/ Troponin localisation after infection after 24h co-culture with <italic>S. A</italic>. The bar is 50μm.</p><p>(E) The distribution pattern of Calponin and α-actinin structures in HCOs before and after <italic>S. A</italic> infection, obtained through Stardist analysis.</p><p>(F) Quantitative analysis of the formed areas of MHC, Troponin, Calponin, and α-actinin before and after infection to demonstrate the extent of structural disruption caused by the infection.</p></caption>
<graphic xlink:href="647814v1_fig7.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2f">
<title>Validation of increasing heart contractility as a potential strategy against bacterial infection</title>
<p>To validate that weakened contractility is key to facilitating bacterial infection of the myocardium, we established a mouse model with reduced cardiac function to observe <italic>S. A</italic> infection. We performed transverse aortic constriction (TAC) surgery to induce cardiac hypertrophy, as confirmed by electrocardiography with significantly lower heart rates (<xref rid="fig8" ref-type="fig">Fig. 8A</xref>). A total of 24 mice were divided into four groups (n=6 per group): i) mock group: mice in this group received a standard PBS and bacteria injection after TAC surgery, serving as a baseline for comparison; ii) amoxicillin group: mice in this group received the 50 mg/mL amoxicillin treatment and bacteria injection after TAC surgery; iii) enalapril group: mice in this group received the 10mg/mL Enalapril treatment and bacteria injection after TAC surgery; iv) sham group: mice in this group received PBS and bacteria injection without TAC surgery. The results of echocardiography also clearly validated this finding, with the sham group exhibiting a more normal electrocardiogram compared to the surgical group (<xref rid="fig8" ref-type="fig">Fig. 8B</xref>). The mice administrated with enalapril exhibited significantly higher cardiac output (Fractional shortening) than those in the mock group. At the same time, the amoxicillin treatment had a much weaker effect (<xref rid="fig8" ref-type="fig">Fig. 8C</xref>). Following surgery, all mice showed instances of tachycardia, which could be a compensatory response to the decreased cardiac function. After surgery and drug administration, we performed bacterial injections in each group. Subsequently, for three days, we administered the corresponding therapeutic drug once daily. The mice were euthanized three days later, and their hearts were collected to observe for any signs of bacterial infection (<xref rid="fig8" ref-type="fig">Fig. 8D</xref>).</p>
<fig id="fig8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8.</label>
<caption><title>Dissecting the influence of contractility on <italic>S. A</italic> infection <italic>in vivo</italic> using mice model.</title><p>(A) Experimental set-up: Mice were assigned into groups (Sham, Mock, Amoxicillin and Enalapril; n=6). All C57Bl/6 mice except the Sham group first received TAC surgery to induce reduced heart function. Different drugs were injected into mice for further experiments.</p><p>(B) Electrocardiography of the mice from different experimental and Sham groups was measured two hours after drug administration.</p><p>(C) Fraction shortening (%) of the mice from different experimental groups and Sham group measured by Electrocardiography at 2h after drug administration.***<italic>P&lt;</italic>0.005 ****<italic>p</italic>&lt;0.001</p><p>(D) The heart specimens collected post-experimentation from different groups.</p><p>(E) The number of deaths, IE on ventricle, and non-IE on ventricle among mice in different experimental groups. The infection status of decimals was confirmed through observation of cardiac bacteria vegetations and Gram staining under a microscope.</p><p>(F) Aortic ventricle endocarditis in different experiment groups. Staining: haematoxylin and eosin (H&amp;E) and Gram staining. The bar is 50 μm</p><p>(G) Comparative analysis of the Fractal Dimension in mice with or without endocarditis in the cardiac ventricles in Enalapril, Mock and Sham groups. Significance:****<italic>p</italic>&lt;0.001</p><p>(H) Comparative analysis of the Fractal Dimension in mice with or without endocarditis in the cardiac valves in Enalapril, Mock and Sham group. Significance:****<italic>p</italic>&lt;0.001</p></caption>
<graphic xlink:href="647814v1_fig8.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Within three days following bacterial injection, one mouse from the amoxicillin group and the mock group died, while no deaths occurred in the enalapril group and the sham group (<xref rid="fig8" ref-type="fig">Fig. 8E</xref>). Enalapril effectively prevented bacterial infection on the ventricle while severe infections were observed in both the amoxicillin and the mock group (<xref rid="fig8" ref-type="fig">Fig. 8F</xref>). Gram staining of the tissue specimen revealed that the ventricles of only one mouse in the Mock group and three in the sham group were infected. Amoxicillin treatment only spared one mouse (n=6) from infection, suggesting its ineffective prevention of <italic>S. A</italic> from ventricle colonization (<xref rid="fig8" ref-type="fig">Fig. 8F</xref>) However, the Enalapril treatment prevented three mice from ventricle infection (n=6), markedly reducing the probability of infection or death by 25% compared with the mock group and 16% compared to the amoxicillin group (<xref rid="fig8" ref-type="fig">Fig. 8G</xref>). The infection scenario in the valves was similar (<xref ref-type="supplementary-material" rid="supp1">Fig. S6A</xref>): enalapril significantly reduced the likelihood of valve infection or death by 16.6%, compared to the amoxicillin treatment and mock group (<xref ref-type="supplementary-material" rid="supp1">Fig. S6B</xref>). Notably, enalapril, aimed at increasing heart contractility but not inhibiting bacteria, performed better than the antibiotic amoxicillin in lowering the infection rate, reaching the same level as the sham group.</p>
<p>We performed statistical comparisons of FS (fractional shortening) and heart rate between mice infected with bacteria and uninfected mice, noting that the cardiac function of mice without ventricle infection was significantly higher by 25% than that in the infected mice (<xref rid="fig8" ref-type="fig">Fig. 8G</xref>). Also, the heart rate of mice increased significantly post-surgery, regardless of drug treatment, as a compensatory response to the decreased cardiac function. However, this elevated heart rate was not related to reduced bacterial infection (<xref ref-type="supplementary-material" rid="supp1">Fig. S6C</xref>). For valve infection; the FS and heart beat rate were both significantly increased (<xref rid="fig8" ref-type="fig">Fig. 8H</xref>, <xref ref-type="supplementary-material" rid="supp1">Fig. S6D</xref>) between mice without valve infection compared to those that were uninfected. These <italic>in vivo</italic> results validated our findings from engineering models correlating weakened myocardial contractility with increased bacterial infection, suggesting that increasing heart contractility, instead of heart beating rate, may become a new therapeutic approach for IE.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>Bacterial infection of the heart tissue can cause endocarditis with a high mortality rate, but the fundamental reason for the failure to resist microbial invasion of the myocardium remains unclear. Traditionally, it is understood that when events like open-heart surgery, trauma, or endothelial inflammation damage the endocardium integrity, bacteria manage to adhere to and invade the myocardium[<xref ref-type="bibr" rid="c41a">41a,b</xref>]. Several reports have also suggested that altered hemodynamics resulting from heart disease can influence cardiac bacterial infections[<xref ref-type="bibr" rid="c42a">42a,b,c</xref>]. However, one major underlying cause of altered hemodynamics[<xref ref-type="bibr" rid="c43">43</xref>], as well as a common underlying condition in many high-risk IE populations[<xref ref-type="bibr" rid="c44">44</xref>], heart failure, has been entirely overlooked.</p>
<p>In this study, by developing quantitative tools for analyzing bacterial-cardiac organoid interactions in a 3D, dynamic, clinically relevant setting, we discovered the significant role of cardiac contractility in preventing bacterial infection. Our created toolbox of live-cell image analysis integrated with the finite element analysis model, for the first time, unraveled the crosstalk between the self-propelled motion of the COs and the infection attempts by bacteria in different stages. The findings that patient-derived DCM-COs with weakened motility failed to resist bacterial adhesion – while healthy donor-derived HCO with strong contractile force managed to – suggest that bacterial infection of the heart is correlated with cardiac motility, even without pathological changes in cardiac valve structures. Interestingly, neither frequency nor pattern of the cardiac motion, as often speculated, played a significant role. Our findings provide fresh insights for possibly devising new contractility-enhancing therapies against endocarditis.</p>
<p>The heart is unique compared to other organs for its self-generated contractile force, which increases the difficulty of studying myocardial infection. The intrinsic contraction of the myocardial tissue and the pathogens’ motility should be considered interactively and quantitatively. Previous studies have provided valuable insights and tools for investigating similar and dynamic systems. For instance, Huebsch et al. developed mathematical models to assess the motion of COs36, and Mills et al. employed advanced systems to assess forces [<xref ref-type="bibr" rid="c45">45</xref>]. Several attempts were made to construct <italic>in vitro</italic> organ models to simulate infections [<xref ref-type="bibr" rid="c12">12</xref>, <xref ref-type="bibr" rid="c46a">46a,b</xref>]. Sauvonnet et al.’s groundbreaking research explored the impact of intestinal peristalsis on bacterial infections, opening the door to studying the dynamics between organs and bacteria[<xref ref-type="bibr" rid="c47a">47a,b</xref>]. These studies have made significant contributions, but the relationship between cardiac cell motility and bacterial infection remained unexplored. We studied the impact of highly mobile cardiac organoids on bacterial infections by integrating physical, mathematical, and biological models. Our study has shed light on the significance of incorporating physical forces into the study of biological systems, with potential implications for understanding heart disease and related conditions.</p>
<p>We integrated cell tracking tools and FEM for live-cell image analysis, which showed unique advantages for analyzing COs’ contractility and COs-bacteria interactions in a real scenario. Utilizing image tracking, our established methods can readily obtain rich data about the motions without relying on any complex apparatus.</p>
<p>The FEM model we utilized here combines ease of operation with greater realism, as it takes into account the material properties of the cells themselves as well as the properties of the water field within the FEM system. The FEM system has been proven to be highly valuable in numerous cardiovascular studies[<xref ref-type="bibr" rid="c20b">20b</xref>, <xref ref-type="bibr" rid="c48a">48a,b</xref>]. We also conducted various statistical approaches to analyze the relationship between organoid movement patterns and adhesion status in different COs. The methodologies established in this study provide powerful tools for future research related to COs.</p>
<p>Importantly, our COs were derived from clinical samples with disease-relevant properties. We have innovatively found that COs with healthy cardiac muscle contractility were resistant to bacterial infection. DCM-COs, which had weak motility with a disease-related heartbeat pattern, did not exhibit this ability. After the contractility of COs was reduced by the toxins secreted during bacterial infection, COs could be infected by bacteria again. The functions of these toxins have been widely studied, and they play a very important role in infection, including adhesion, destruction of cell structures, and motility[<xref ref-type="bibr" rid="c37b">37b</xref>, <xref ref-type="bibr" rid="c37c">37c</xref>, <xref ref-type="bibr" rid="c49a">49a,b</xref>]. Our results agree with real clinical outcomes in either the contractile pattern or the contribution of toxins.</p>
<p>Several limitations of this study also inspire future directions. First, we only considered the self-propelled fluid motion of the organoids. Although the fluid motion in the body is also driven by the heart, the presence of the ventricles and blood vessels results in a different fluid form. Constructing a heart-like organ system using microfluidics can provide a more realistic fluidic environment for studying the interactions between bacteria and the host. Second, the role of immune cells is also crucial in understanding infectious diseases of any tissue. It is important to acknowledge the presence of resident macrophages, albeit in small numbers[<xref ref-type="bibr" rid="c50a">50a,b</xref>], among other immunocytes. At the same time, it is worth investigating how the heartbeat affects blood cells in the cardiovascular system during activation and migration. The different motility of the heart may guide the activation and adhesion of immune cells in a different direction). Third, the field still lacks research on bacteria and cells’ temporal and spatial gene expression during infection. To address this, more comprehensive techniques such as spatiotemporal transcriptomics and single-cell sequencing can provide detailed information about the gene expression of cells at different layers and the genomic expression of bacteria at different stages of infection. Finally, the degree of maturation of the organoids is also worth further optimization. In our study, we only observed the presence of some cavity-like structure within the organoids. This basic structure would be sufficient for simulating basic bacterial adhesion, similar to the organoids used by Richards et al[<xref ref-type="bibr" rid="c10">10</xref>]., in their simulation of myocardial infarction. For more accurately understanding the various stages of infection and the detailed host-microbe dynamics, more mature COs with well-developed lumen structures may also be necessary, as demonstrated previously by Hofbauer, P. et al[<xref ref-type="bibr" rid="c13a">13a</xref>].</p>
</sec>
</body>
<back>
<sec id="additional-files" sec-type="supplementary-material">
<title>Additional files</title>
<supplementary-material id="methods">
<label>Methods</label>
<media mimetype="application" mime-subtype="pdf" xlink:href="methods.pdf"/>
</supplementary-material>
<supplementary-material id="supp1">
<label>Supplementary file 1.</label>
<media mimetype="application" mime-subtype="pdf" xlink:href="supp1.pdf"/>
</supplementary-material>
<supplementary-material id="supp2">
<label>Supplementary file 2.</label>
<media mimetype="application" mime-subtype="pdf" xlink:href="supp2.pdf"/>
</supplementary-material>
<supplementary-material id="video1">
<label>Video 1.</label>
<media mimetype="video" mime-subtype="avi" xlink:href="video1.avi"/>
</supplementary-material>
<supplementary-material id="video2">
<label>Video 2.</label>
<media mimetype="video" mime-subtype="avi" xlink:href="video2.avi"/>
</supplementary-material>
<supplementary-material id="video3">
<label>Video 3.</label>
<media mimetype="video" mime-subtype="mp4" xlink:href="video3.mp4"/>
</supplementary-material>
<supplementary-material id="video4">
<label>Video 4.</label>
<media mimetype="video" mime-subtype="avi" xlink:href="video4.avi"/>
</supplementary-material>
<supplementary-material id="video5">
<label>Video 5.</label>
<media mimetype="video" mime-subtype="avi" xlink:href="video5.avi"/>
</supplementary-material>
<supplementary-material id="video6">
<label>Video 6.</label>
<media mimetype="video" mime-subtype="mp4" xlink:href="video6.mp4"/>
</supplementary-material>
<supplementary-material id="video7">
<label>Video 7.</label>
<media mimetype="video" mime-subtype="avi" xlink:href="video7.avi"/>
</supplementary-material>
<supplementary-material id="video8">
<label>Video 8.</label>
<media mimetype="video" mime-subtype="avi" xlink:href="video8.avi"/>
</supplementary-material>
<supplementary-material id="video9">
<label>Video 9.</label>
<media mimetype="video" mime-subtype="avi" xlink:href="video9.avi"/>
</supplementary-material>
<supplementary-material id="video10">
<label>Video 10.</label>
<media mimetype="video" mime-subtype="avi" xlink:href="video10.avi"/>
</supplementary-material>
</sec>
<ref-list>
<title>Reference</title>
<ref id="c1a"><label>[1a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>T. J.</given-names> <surname>Cahill</surname></string-name>, <string-name><given-names>L. M.</given-names> <surname>Baddour</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Habib</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Hoen</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Salaun</surname></string-name>, <string-name><given-names>G. B.</given-names> <surname>Pettersson</surname></string-name>, <string-name><given-names>H. J.</given-names> <surname>Schäfers</surname></string-name>, <string-name><given-names>B. D.</given-names> <surname>Prendergast</surname></string-name></person-group>, <source>Journal of the american college of cardiology</source> <year>2017</year>, <volume>69</volume>, <fpage>325</fpage>–<lpage>344</lpage>;</mixed-citation></ref>
<ref id="c1b"><label>[1b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>E.</given-names> <surname>Mylonakis</surname></string-name>, <string-name><given-names>S. B.</given-names> <surname>Calderwood</surname></string-name></person-group>, <source>New England Journal of Medicine</source> <year>2001</year>, <volume>345</volume>, <fpage>1318</fpage>–<lpage>1330</lpage>.</mixed-citation></ref>
<ref id="c2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>R. G.</given-names> <surname>Norenberg</surname></string-name>, <string-name><given-names>G. K.</given-names> <surname>Sethi</surname></string-name>, <string-name><given-names>S. M.</given-names> <surname>Scott</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Takaro</surname></string-name></person-group>, <source>The Annals of Thoracic Surgery</source> <year>1975</year>, <volume>19</volume>, <fpage>592</fpage>–<lpage>604</lpage>.</mixed-citation></ref>
<ref id="c3a"><label>[3a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>M. H.</given-names> <surname>Thornhill</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Jones</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Prendergast</surname></string-name>, <string-name><given-names>L. M.</given-names> <surname>Baddour</surname></string-name>, <string-name><given-names>J. B.</given-names> <surname>Chambers</surname></string-name>, <string-name><given-names>P. B.</given-names> <surname>Lockhart</surname></string-name>, <string-name><given-names>M. J.</given-names> <surname>Dayer</surname></string-name></person-group>, <source>European heart journal</source> <year>2018</year>, <volume>39</volume>, <fpage>586</fpage>–<lpage>595</lpage>;</mixed-citation></ref>
<ref id="c3b"><label>[3b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>L.</given-names> <surname>Østergaard</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Valeur</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Ihlemann</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Bundgaard</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Gislason</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Torp-Pedersen</surname></string-name>, <string-name><given-names>N. E.</given-names> <surname>Bruun</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Søndergaard</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Køber</surname></string-name>, <string-name><given-names>E. L.</given-names> <surname>Fosbøl</surname></string-name></person-group>, <source>European heart journal</source> <year>2018</year>, <volume>39</volume>, <fpage>623</fpage>–<lpage>629</lpage>;</mixed-citation></ref>
<ref id="c3c"><label>[3c]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>R.</given-names> <surname>Erbel</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Ge</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Rohmann</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Kupferwasser</surname></string-name></person-group>, <source>European heart journal</source> <year>1995</year>, <volume>16</volume>, <fpage>588</fpage>–<lpage>602</lpage>.</mixed-citation></ref>
<ref id="c4a"><label>[4a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>T.</given-names> <surname>Kiefer</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Park</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Tribouilloy</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Cortes</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Casillo</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Chu</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Delahaye</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Durante-Mangoni</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Edathodu</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Falces</surname></string-name></person-group>, <source>Jama</source> <year>2011</year>, <volume>306</volume>, <fpage>2239</fpage>–<lpage>2247</lpage>;</mixed-citation></ref>
<ref id="c4b"><label>[4b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>C.</given-names> <surname>Davies</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Davia</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Bennett</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Pepper</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Poole-Wilson</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Harding</surname></string-name></person-group>, <source>Circulation</source> <year>1995</year>, <volume>92</volume>, <fpage>2540</fpage>–<lpage>2549</lpage>;</mixed-citation></ref>
<ref id="c4c"><label>[4c]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>S. J.</given-names> <surname>Pocock</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>Pfeffer</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Yusuf</surname></string-name>, <string-name><given-names>J. J.</given-names> <surname>McMurray</surname></string-name>, <string-name><given-names>K. B.</given-names> <surname>Swedberg</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Ostergren</surname></string-name>, <string-name><given-names>E. L.</given-names> <surname>Michelson</surname></string-name>, <string-name><given-names>K. S.</given-names> <surname>Pieper</surname></string-name>, <string-name><given-names>C. B.</given-names> <surname>Granger</surname></string-name></person-group>, <source>European heart journal</source> <year>2006</year>, <volume>27</volume>, <fpage>65</fpage>–<lpage>75</lpage>.</mixed-citation></ref>
<ref id="c5a"><label>[5a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>K. A.</given-names> <surname>Kline</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Fälker</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Dahlberg</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Normark</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Henriques-Normark</surname></string-name></person-group>, <source>Cell host &amp; microbe</source> <year>2009</year>, <volume>5</volume>, <fpage>580</fpage>–<lpage>592</lpage>;</mixed-citation></ref>
<ref id="c5b"><label>[5b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>J.</given-names> <surname>Pizarro-Cerdá</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Cossart</surname></string-name></person-group>, <source>Cell</source> <year>2006</year>, <volume>124</volume>, <fpage>715</fpage>–<lpage>727</lpage>.</mixed-citation></ref>
<ref id="c6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>H. H.</given-names> <surname>Rijnaarts</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Norde</surname></string-name>, <string-name><given-names>E. J.</given-names> <surname>Bouwer</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Lyklema</surname></string-name>, <string-name><given-names>A. J.</given-names> <surname>Zehnder</surname></string-name></person-group>, <source>Applied and Environmental Microbiology</source> <year>1993</year>, <volume>59</volume>, <fpage>3255</fpage>–<lpage>3265</lpage>.</mixed-citation></ref>
<ref id="c7a"><label>[7a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>R. R.</given-names> <surname>Isberg</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Barnes</surname></string-name></person-group>, <source>Cell</source> <year>2002</year>, <volume>110</volume>, <fpage>1</fpage>–<lpage>4</lpage>;</mixed-citation></ref>
<ref id="c7b"><label>[7b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>Z.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>A. M.</given-names> <surname>Vera</surname></string-name>, <string-name><given-names>R. C.</given-names> <surname>Bernardi</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Tinnefeld</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>Nash</surname></string-name></person-group>, <source>Nature communications</source> <year>2020</year>, <volume>11</volume>, <fpage>4321</fpage>.</mixed-citation></ref>
<ref id="c8"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>S.</given-names> <surname>Zheng</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Bawazir</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Dhall</surname></string-name>, <string-name><given-names>H.-E.</given-names> <surname>Kim</surname></string-name>, <string-name><given-names>L.</given-names> <surname>He</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Heo</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Hwang</surname></string-name></person-group>, <source>Frontiers in Bioengineering and Biotechnology</source> <year>2021</year>, <volume>9</volume>, <fpage>643722</fpage>.</mixed-citation></ref>
<ref id="c9"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>E.</given-names> <surname>Secchi</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Vitale</surname></string-name>, <string-name><given-names>G. L.</given-names> <surname>Miño</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Kantsler</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Eberl</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Rusconi</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Stocker</surname></string-name></person-group>, <source>Nature communications</source> <year>2020</year>, <volume>11</volume>, <fpage>2851</fpage>.</mixed-citation></ref>
<ref id="c10"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>D. J.</given-names> <surname>Richards</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>C. M.</given-names> <surname>Kerr</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Yao</surname></string-name>, <string-name><given-names>G. C.</given-names> <surname>Beeson</surname></string-name>, <string-name><given-names>R. C.</given-names> <surname>Coyle</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Jia</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Damon</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Wilson</surname></string-name></person-group>, <source>Nature Biomedical Engineering</source> <year>2020</year>, <volume>4</volume>, <fpage>446</fpage>–<lpage>462</lpage>.</mixed-citation></ref>
<ref id="c11"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>H.</given-names> <surname>Kim</surname></string-name>, <string-name><given-names>R. D.</given-names> <surname>Kamm</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Vunjak-Novakovic</surname></string-name>, <string-name><given-names>J. C.</given-names> <surname>Wu</surname></string-name></person-group>, <source>Cell Stem Cell</source> <year>2022</year>, <volume>29</volume>, <fpage>503</fpage>–<lpage>514</lpage>.</mixed-citation></ref>
<ref id="c12"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>J.</given-names> <surname>Puschhof</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Pleguezuelos-Manzano</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Martinez-Silgado</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Akkerman</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Saftien</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Boot</surname></string-name>, <string-name><given-names>A.</given-names> <surname>de Waal</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Beumer</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Dutta</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Heo</surname></string-name></person-group>, <source>Nature protocols</source> <year>2021</year>, <volume>16</volume>, <fpage>4633</fpage>–<lpage>4649</lpage>.</mixed-citation></ref>
<ref id="c13a"><label>[13a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>P.</given-names> <surname>Hofbauer</surname></string-name>, <string-name><given-names>S. M.</given-names> <surname>Jahnel</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Papai</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Giesshammer</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Deyett</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Schmidt</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Penc</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Tavernini</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Grdseloff</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Meledeth</surname></string-name></person-group>, <source>Cell</source> <year>2021</year>, <volume>184</volume>, <fpage>3299</fpage>–<lpage>3317.e3222</lpage>;</mixed-citation></ref>
<ref id="c13b"><label>[13b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>G.</given-names> <surname>Rossi</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Broguiere</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Miyamoto</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Boni</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Guiet</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Girgin</surname></string-name>, <string-name><given-names>R. G.</given-names> <surname>Kelly</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Kwon</surname></string-name>, <string-name><given-names>M. P.</given-names> <surname>Lutolf</surname></string-name></person-group>, <source>Cell stem cell</source> <year>2021</year>, <volume>28</volume>, <fpage>230</fpage>–<lpage>240.e236</lpage>;</mixed-citation></ref>
<ref id="c13c"><label>[13c]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>L.</given-names> <surname>Drakhlis</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Biswanath</surname></string-name>, <string-name><given-names>C.-M.</given-names> <surname>Farr</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Lupanow</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Teske</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Ritzenhoff</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Franke</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Manstein</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Bolesani</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Kempf</surname></string-name></person-group>, <source>Nature Biotechnology</source> <year>2021</year>, <volume>39</volume>, <fpage>737</fpage>–<lpage>746</lpage>.</mixed-citation></ref>
<ref id="c14"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>D.</given-names> <surname>Zhao</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Lei</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Hu</surname></string-name></person-group>, <source>Stem Cell Research &amp; Therapy</source> <year>2021</year>, <volume>12</volume>, <fpage>1</fpage>–<lpage>10</lpage>.</mixed-citation></ref>
<ref id="c15a"><label>[15a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>R. K.</given-names> <surname>Iyer</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Chui</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Radisic</surname></string-name></person-group>, <source>Journal of tissue engineering and regenerative medicine</source> <year>2009</year>, <volume>3</volume>, <fpage>196</fpage>–<lpage>207</lpage>;</mixed-citation></ref>
<ref id="c15b"><label>[15b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>J. P.</given-names> <surname>Singaraju</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Kadiresan</surname></string-name>, <string-name><given-names>R. K.</given-names> <surname>Bhoi</surname></string-name>, <string-name><given-names>A. H.</given-names> <surname>Gomez</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Ma</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Yang</surname></string-name></person-group>, <source>Tissue Engineering Part C: Methods</source> <year>2023</year>, <volume>29</volume>, <fpage>572</fpage>–<lpage>582</lpage>.</mixed-citation></ref>
<ref id="c16"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A. N.</given-names> <surname>Rosenbaum</surname></string-name>, <string-name><given-names>K. E.</given-names> <surname>Agre</surname></string-name>, <string-name><given-names>N. L.</given-names> <surname>Pereira</surname></string-name></person-group>, <source>Nature Reviews Cardiology</source> <year>2020</year>, <volume>17</volume>, <fpage>286</fpage>–<lpage>297</lpage>.</mixed-citation></ref>
<ref id="c17"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A. S.</given-names> <surname>Werner</surname></string-name>, <string-name><given-names>C. G.</given-names> <surname>Cobbs</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Kaye</surname></string-name>, <string-name><given-names>E. W.</given-names> <surname>Hook</surname></string-name></person-group>, <source>Jama</source> <year>1967</year>, <volume>202</volume>, <fpage>199</fpage>–<lpage>203</lpage>.</mixed-citation></ref>
<ref id="c18"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A. G.</given-names> <surname>Japp</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Gulati</surname></string-name>, <string-name><given-names>S. A.</given-names> <surname>Cook</surname></string-name>, <string-name><given-names>M. R.</given-names> <surname>Cowie</surname></string-name>, <string-name><given-names>S. K.</given-names> <surname>Prasad</surname></string-name></person-group>, <source>Journal of the American college of cardiology</source> <year>2016</year>, <volume>67</volume>, <fpage>2996</fpage>–<lpage>3010</lpage>.</mixed-citation></ref>
<ref id="c19"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>R. G.</given-names> <surname>Weintraub</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Semsarian</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Macdonald</surname></string-name></person-group>, <source>The Lancet</source> <year>2017</year>, <volume>390</volume>, <fpage>400</fpage>–<lpage>414</lpage>.</mixed-citation></ref>
<ref id="c20a"><label>[20a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>E.</given-names> <surname>Dumont</surname></string-name>, <string-name><given-names>I. R.</given-names> <surname>Grosse</surname></string-name>, <string-name><given-names>G. J.</given-names> <surname>Slater</surname></string-name></person-group>, <source>Journal of Theoretical Biology</source> <year>2009</year>, <volume>256</volume>, <fpage>96</fpage>–<lpage>103</lpage>;</mixed-citation></ref>
<ref id="c20b"><label>[20b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>H. J.</given-names> <surname>Kim</surname></string-name>, <string-name><given-names>I. E.</given-names> <surname>Vignon-Clementel</surname></string-name>, <string-name><given-names>C. A.</given-names> <surname>Figueroa</surname></string-name>, <string-name><given-names>J. F.</given-names> <surname>LaDisa</surname></string-name>, <string-name><given-names>K. E.</given-names> <surname>Jansen</surname></string-name>, <string-name><given-names>J. A.</given-names> <surname>Feinstein</surname></string-name>, <string-name><given-names>C. A.</given-names> <surname>Taylor</surname></string-name></person-group>, <source>Annals of biomedical engineering</source> <year>2009</year>, <volume>37</volume>, <fpage>2153</fpage>–<lpage>2169</lpage>.</mixed-citation></ref>
<ref id="c21"><label>[21]</label><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><given-names>S.</given-names> <surname>Sugiura</surname></string-name>, <string-name><given-names>J.-I.</given-names> <surname>Okada</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Washio</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Hisada</surname></string-name></person-group>, in <source>Computational Systems Biology in Medicine and Biotechnology: Methods and Protocols</source>, <publisher-name>Springer</publisher-name>, <year>2022</year>, pp. <fpage>221</fpage>–<lpage>245</lpage>.</mixed-citation></ref>
<ref id="c22"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>H.</given-names> <surname>Watanabe</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Sugiura</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Kafuku</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Hisada</surname></string-name></person-group>, <source>Biophysical journal</source> <year>2004</year>, <volume>87</volume>, <fpage>2074</fpage>–<lpage>2085</lpage>.</mixed-citation></ref>
<ref id="c23"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>K.</given-names> <surname>Rajala</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Pekkanen-Mattila</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Aalto-Setälä</surname></string-name></person-group>, <source>Stem cells international</source> <year>2011</year>, <fpage>2011</fpage>.</mixed-citation></ref>
<ref id="c24a"><label>[24a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>G.</given-names> <surname>Captur</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Arbustini</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Bonne</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Syrris</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Mills</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Wahbi</surname></string-name>, <string-name><given-names>S. A.</given-names> <surname>Mohiddin</surname></string-name>, <string-name><given-names>W. J.</given-names> <surname>McKenna</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Pettit</surname></string-name>, <string-name><given-names>C. Y.</given-names> <surname>Ho</surname></string-name></person-group>, <source>Heart</source> <year>2018</year>, <volume>104</volume>, <fpage>468</fpage>–<lpage>479</lpage>;</mixed-citation></ref>
<ref id="c24b"><label>[24b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>V.</given-names> <surname>Nikolova</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Leimena</surname></string-name>, <string-name><given-names>A. C.</given-names> <surname>McMahon</surname></string-name>, <string-name><given-names>J. C.</given-names> <surname>Tan</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Chandar</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Jogia</surname></string-name>, <string-name><given-names>S. H.</given-names> <surname>Kesteven</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Michalicek</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Otway</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Verheyen</surname></string-name></person-group>, <source>The Journal of clinical investigation</source> <year>2004</year>, <volume>113</volume>, <fpage>357</fpage>–<lpage>369</lpage>;</mixed-citation></ref>
<ref id="c24c"><label>[24c]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>P.</given-names> <surname>Sebillon</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Bouchier</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Bidot</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Bonne</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Ahamed</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Charron</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Drouin-Garraud</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Millaire</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Desrumeaux</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Benaïche</surname></string-name></person-group>, <source>Journal of medical genetics</source> <year>2003</year>, <volume>40</volume>, <fpage>560</fpage>–<lpage>567</lpage>.</mixed-citation></ref>
<ref id="c25"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>F.</given-names> <surname>De Frutos</surname></string-name>, <string-name><given-names>J. P.</given-names> <surname>Ochoa</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Navarro-Peñalver</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Baas</surname></string-name>, <string-name><given-names>J. V.</given-names> <surname>Bjerre</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Zorio</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Méndez</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Lorca</surname></string-name>, <string-name><given-names>J. A.</given-names> <surname>Verdonschot</surname></string-name>, <string-name><given-names>P. E.</given-names> <surname>García-Granja</surname></string-name></person-group>, <source>Journal of the American College of Cardiology</source> <year>2022</year>, <volume>80</volume>, <fpage>1447</fpage>–<lpage>1461</lpage>.</mixed-citation></ref>
<ref id="c26a"><label>[26a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>J.-Y.</given-names> <surname>Tinevez</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Perry</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Schindelin</surname></string-name>, <string-name><given-names>G. M.</given-names> <surname>Hoopes</surname></string-name>, <string-name><given-names>G. D.</given-names> <surname>Reynolds</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Laplantine</surname></string-name>, <string-name><given-names>S. Y.</given-names> <surname>Bednarek</surname></string-name>, <string-name><given-names>S. L.</given-names> <surname>Shorte</surname></string-name>, <string-name><given-names>K. W.</given-names> <surname>Eliceiri</surname></string-name></person-group>, <source>Methods</source> <year>2017</year>, <volume>115</volume>, <fpage>80</fpage>–<lpage>90</lpage>;</mixed-citation></ref>
<ref id="c26b"><label>[26b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>K.</given-names> <surname>Jaqaman</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Loerke</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Mettlen</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Kuwata</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Grinstein</surname></string-name>, <string-name><given-names>S. L.</given-names> <surname>Schmid</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Danuser</surname></string-name></person-group>, <source>Nature methods</source> <year>2008</year>, <volume>5</volume>, <fpage>695</fpage>–<lpage>702</lpage>.</mixed-citation></ref>
<ref id="c27"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>M.</given-names> <surname>Ghosheh</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Ehrlich</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Ioannidis</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Ayyash</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Goldfracht</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Cohen</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Fischer</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Mintz</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Gepstein</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Nahmias</surname></string-name></person-group>, <source>Nature biomedical engineering</source> <year>2023</year>, <volume>7</volume>, <fpage>1493</fpage>–<lpage>1513</lpage>.</mixed-citation></ref>
<ref id="c28a"><label>[28a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>L.</given-names> <surname>Liesenborghs</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Meyers</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Lox</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Criel</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Claes</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Peetermans</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Trenson</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Vande Velde</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Vanden Berghe</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Baatsen</surname></string-name></person-group>, <source>European heart journal</source> <year>2019</year>, <volume>40</volume>, <fpage>3248</fpage>–<lpage>3259</lpage>;</mixed-citation></ref>
<ref id="c28b"><label>[28b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>L.</given-names> <surname>Liesenborghs</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Meyers</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Vanassche</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Verhamme</surname></string-name></person-group>, <source>Journal of Thrombosis and Haemostasis</source> <year>2020</year>, <volume>18</volume>, <fpage>995</fpage>–<lpage>1008</lpage>;</mixed-citation></ref>
<ref id="c28c"><label>[28c]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A. M.</given-names> <surname>Müller</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Cronen</surname></string-name>, <string-name><given-names>L. I.</given-names> <surname>Kupferwasser</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Oelert</surname></string-name>, <string-name><given-names>K. M.</given-names> <surname>Müller</surname></string-name>, <string-name><given-names>C. J.</given-names> <surname>Kirkpatrick</surname></string-name></person-group>, <source>The Journal of pathology</source> <year>2000</year>, <volume>191</volume>, <fpage>54</fpage>–<lpage>60</lpage>.</mixed-citation></ref>
<ref id="c29a"><label>[29a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>D.</given-names> <surname>Ershov</surname></string-name>, <string-name><given-names>M.-S.</given-names> <surname>Phan</surname></string-name>, <string-name><given-names>J. W.</given-names> <surname>Pylvänäinen</surname></string-name>, <string-name><given-names>S. U.</given-names> <surname>Rigaud</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Le Blanc</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Charles-Orszag</surname></string-name>, <string-name><given-names>J. R.</given-names> <surname>Conway</surname></string-name>, <string-name><given-names>R. F.</given-names> <surname>Laine</surname></string-name>, <string-name><given-names>N. H.</given-names> <surname>Roy</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Bonazzi</surname></string-name></person-group>, <source>Nature Methods</source> <year>2022</year>, <volume>19</volume>, <fpage>829</fpage>–<lpage>832</lpage>;</mixed-citation></ref>
<ref id="c29b"><label>[29b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A. C.</given-names> <surname>Flint</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Conell</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Ren</surname></string-name>, <string-name><given-names>N. M.</given-names> <surname>Banki</surname></string-name>, <string-name><given-names>S. L.</given-names> <surname>Chan</surname></string-name>, <string-name><given-names>V. A.</given-names> <surname>Rao</surname></string-name>, <string-name><given-names>R. B.</given-names> <surname>Melles</surname></string-name>, <string-name><given-names>D. L.</given-names> <surname>Bhatt</surname></string-name></person-group>, <source>New England Journal of Medicine</source> <year>2019</year>, <volume>381</volume>, <fpage>243</fpage>–<lpage>251</lpage>.</mixed-citation></ref>
<ref id="c30a"><label>[30a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>O.</given-names> <surname>Barquero-Perez</surname></string-name>, <string-name><given-names>J. L.</given-names> <surname>Rojo-Alvarez</surname></string-name>, <string-name><given-names>A. J.</given-names> <surname>Caamano</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Goya-Esteban</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Everss</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Alonso-Atienza</surname></string-name>, <string-name><given-names>J. J.</given-names> <surname>Sánchez-Munoz</surname></string-name>, <string-name><given-names>A.</given-names> <surname>García-Alberola</surname></string-name></person-group>, <source>IEEE Transactions on Biomedical Engineering</source> <year>2010</year>, <volume>57</volume>, <fpage>2168</fpage>–<lpage>2177</lpage>;</mixed-citation></ref>
<ref id="c30b"><label>[30b]</label><mixed-citation publication-type="confproc"><person-group person-group-type="author"><string-name><given-names>J.</given-names> <surname>Kubicek</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Penhaker</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Kahankova</surname></string-name></person-group>, in <year>2014</year> <conf-name>International Conference on Advances in Computing, Communications and Informatics (ICACCI), IEEE</conf-name>, <year>2014</year>, pp. <fpage>1881</fpage>–<lpage>1885</lpage>.</mixed-citation></ref>
<ref id="c31"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>M. J.</given-names> <surname>Patterson</surname></string-name>,  ; <string-name><given-names>E. J.</given-names> <surname>Pollitt</surname></string-name>, <string-name><given-names>S. P.</given-names> <surname>Diggle</surname></string-name></person-group><source>Streptococcus, Medical Microbiology</source> <year>1996</year>; <source>b</source>, , <source>Cellular and Molecular Life Sciences</source> <year>2017</year>, <volume>74</volume>, <fpage>2943</fpage>–<lpage>2958</lpage>.</mixed-citation></ref>
<ref id="c32a"><label>[32a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>Q.</given-names> <surname>Huang</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Wu</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Cai</surname></string-name>, <string-name><given-names>J. B.</given-names> <surname>Fein</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Chen</surname></string-name></person-group>, <source>Scientific reports</source> <year>2015</year>, <volume>5</volume>, <fpage>16857</fpage>;</mixed-citation></ref>
<ref id="c32b"><label>[32b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>Y.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>H. J.</given-names> <surname>Busscher</surname></string-name>, <string-name><given-names>H. C.</given-names> <surname>van der Mei</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Norde</surname></string-name></person-group>, <source>Applied and environmental microbiology</source> <year>2011</year>, <volume>77</volume>, <fpage>5065</fpage>–<lpage>5070</lpage>.</mixed-citation></ref>
<ref id="c33a"><label>[33a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>M. E.</given-names> <surname>Kupfer</surname></string-name>, <string-name><given-names>W.-H.</given-names> <surname>Lin</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Ravikumar</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Qiu</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Gao</surname></string-name>, <string-name><given-names>D. B.</given-names> <surname>Bhuiyan</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Lenz</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Ai</surname></string-name>, <string-name><given-names>R. R.</given-names> <surname>Mahutga</surname></string-name></person-group>, <source>Circulation research</source> <year>2020</year>, <volume>127</volume>, <fpage>207</fpage>–<lpage>224</lpage>;</mixed-citation></ref>
<ref id="c33b"><label>[33b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>P.</given-names> <surname>Pérez-Treviño</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Sepúlveda-Leal</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Altamirano</surname></string-name></person-group>, <source>Cell Calcium</source> <year>2020</year>, <volume>86</volume>, <fpage>102138</fpage>.</mixed-citation></ref>
<ref id="c34a"><label>[34a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>G. W.</given-names> <surname>Abbott</surname></string-name></person-group>, <source>Gene</source> <year>2016</year>, <volume>593</volume>, <fpage>249</fpage>–<lpage>260</lpage>;</mixed-citation></ref>
<ref id="c34b"><label>[34b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>Z.</given-names> <surname>Zeng</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Tan</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Teng</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Su</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Zhou</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Gu</surname></string-name>, <string-name><given-names>J. C.</given-names> <surname>Makielski</surname></string-name></person-group>, <source>Cardiology</source> <year>2007</year>, <volume>108</volume>, <fpage>97</fpage>–<lpage>103</lpage>.</mixed-citation></ref>
<ref id="c35a"><label>[35a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>F.</given-names> <surname>Black</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Packer</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Parker</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Michael</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Roberts</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Schwartz</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Schneider</surname></string-name></person-group>, <source>The Journal of clinical investigation</source> <year>1991</year>, <volume>88</volume>, <fpage>1581</fpage>–<lpage>1588</lpage>;</mixed-citation></ref>
<ref id="c35b"><label>[35b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>D. L.</given-names> <surname>Ruzicka</surname></string-name>, <string-name><given-names>R. J.</given-names> <surname>Schwartz</surname></string-name></person-group>, <source>The Journal of cell biology</source> <year>1988</year>, <volume>107</volume>, <fpage>2575</fpage>–<lpage>2586</lpage>.</mixed-citation></ref>
<ref id="c36"><label>[36]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>M.</given-names> <surname>Benoit</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Thuny</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Le Priol</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Lepidi</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Bastonero</surname></string-name>, <string-name><given-names>J.-P.</given-names> <surname>Casalta</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Collart</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Capo</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Raoult</surname></string-name>, <string-name><given-names>J.-L.</given-names> <surname>Mege</surname></string-name></person-group>, <source>PLoS one</source> <year>2010</year>, <volume>5</volume>, <fpage>e8939</fpage>.</mixed-citation></ref>
<ref id="c37a"><label>[37a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>P.</given-names> <surname>Zhou</surname></string-name>, <string-name><given-names>W. T.</given-names> <surname>Pu</surname></string-name></person-group>, Vol. <volume>118</volume>, <source>Am Heart Assoc</source>, <year>2016</year>, pp. <fpage>368</fpage>–<lpage>370</lpage>;</mixed-citation></ref>
<ref id="c37b"><label>[37b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A. S.</given-names> <surname>Bayer</surname></string-name>, <string-name><given-names>M. D.</given-names> <surname>Ramos</surname></string-name>, <string-name><given-names>B. E.</given-names> <surname>Menzies</surname></string-name>, <string-name><given-names>M. R.</given-names> <surname>Yeaman</surname></string-name>, <string-name><given-names>A. J.</given-names> <surname>Shen</surname></string-name>, <string-name><given-names>A. L.</given-names> <surname>Cheung</surname></string-name></person-group>, <source>Infection and immunity</source> <year>1997</year>, <volume>65</volume>, <fpage>4652</fpage>–<lpage>4660</lpage>;</mixed-citation></ref>
<ref id="c37c"><label>[37c]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>W.</given-names> <surname>Salgado-Pabón</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Breshears</surname></string-name>, <string-name><given-names>A. R.</given-names> <surname>Spaulding</surname></string-name>, <string-name><given-names>J. A.</given-names> <surname>Merriman</surname></string-name>, <string-name><given-names>C. S.</given-names> <surname>Stach</surname></string-name>, <string-name><given-names>A. R.</given-names> <surname>Horswill</surname></string-name>, <string-name><given-names>M. L.</given-names> <surname>Peterson</surname></string-name>, <string-name><given-names>P. M.</given-names> <surname>Schlievert</surname></string-name></person-group>, <source>MBio</source> <year>2013</year>, <volume>4</volume>, <pub-id pub-id-type="doi">10.1128/mbio.00494-00413</pub-id>.</mixed-citation></ref>
<ref id="c38"><label>[38]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>M. M.</given-names> <surname>Dinges</surname></string-name>, <string-name><given-names>P. M.</given-names> <surname>Orwin</surname></string-name>, <string-name><given-names>P. M.</given-names> <surname>Schlievert</surname></string-name></person-group>, <source>Clinical microbiology reviews</source> <year>2000</year>, <volume>13</volume>, <fpage>16</fpage>–<lpage>34</lpage>.</mixed-citation></ref>
<ref id="c39"><label>[39]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>B. J.</given-names> <surname>Berube</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Bubeck Wardenburg</surname></string-name></person-group>, <source>Toxins</source> <year>2013</year>, <volume>5</volume>, <fpage>1140</fpage>–<lpage>1166</lpage>.</mixed-citation></ref>
<ref id="c40"><label>[40]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>N. K.</given-names> <surname>Sweitzer</surname></string-name>, <string-name><given-names>R. L.</given-names> <surname>Moss</surname></string-name></person-group>, <source>Circulation research</source> <year>1993</year>, <volume>73</volume>, <fpage>1150</fpage>–<lpage>1162</lpage>.</mixed-citation></ref>
<ref id="c41a"><label>[41a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>K.</given-names> <surname>Werdan</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Dietz</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Loeffler</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Niemann</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Bushnaq</surname></string-name>, <string-name><given-names>R.-E.</given-names> <surname>Silber</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Peters</surname></string-name>, <string-name><given-names>U.</given-names> <surname>Mueller-Werdan</surname></string-name></person-group>, <source>Nature Reviews Cardiology</source> <year>2014</year>, <volume>11</volume>, <fpage>35</fpage>–<lpage>50</lpage>;</mixed-citation></ref>
<ref id="c41b"><label>[41b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>F.</given-names> <surname>Thuny</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Grisoli</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Collart</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Habib</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Raoult</surname></string-name></person-group>, <source>The Lancet</source> <year>2012</year>, <volume>379</volume>, <fpage>965</fpage>–<lpage>975</lpage>.</mixed-citation></ref>
<ref id="c42a"><label>[42a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>L. M.</given-names> <surname>Baddour</surname></string-name>, <string-name><given-names>W. R.</given-names> <surname>Wilson</surname></string-name>, <string-name><given-names>A. S.</given-names> <surname>Bayer</surname></string-name>, <string-name><given-names>V. G.</given-names> <surname>Fowler Jr</surname></string-name>, <string-name><given-names>I. M.</given-names> <surname>Tleyjeh</surname></string-name>, <string-name><given-names>M. J.</given-names> <surname>Rybak</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Barsic</surname></string-name>, <string-name><given-names>P. B.</given-names> <surname>Lockhart</surname></string-name>, <string-name><given-names>M. H.</given-names> <surname>Gewitz</surname></string-name>, <string-name><given-names>M. E.</given-names> <surname>Levison</surname></string-name></person-group>, <source>Circulation</source> <year>2015</year>, <volume>132</volume>, <fpage>1435</fpage>–<lpage>1486</lpage>;</mixed-citation></ref>
<ref id="c42b"><label>[42b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>G.</given-names> <surname>Thiene</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Basso</surname></string-name></person-group>, <source>Cardiovascular Pathology</source> <year>2006</year>, <volume>15</volume>, <fpage>256</fpage>–<lpage>263</lpage>;</mixed-citation></ref>
<ref id="c42c"><label>[42c]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>I. J.</given-names> <surname>Amat-Santos</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Messika-Zeitoun</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Eltchaninoff</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Kapadia</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Lerakis</surname></string-name>, <string-name><given-names>A. N.</given-names> <surname>Cheema</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Gutiérrez-Ibanes</surname></string-name>, <string-name><given-names>A. J.</given-names> <surname>Munoz-Garcia</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Pan</surname></string-name>, <string-name><given-names>J. G.</given-names> <surname>Webb</surname></string-name></person-group>, <source>Circulation</source> <year>2015</year>, <volume>131</volume>, <fpage>1566</fpage>–<lpage>1574</lpage>.</mixed-citation></ref>
<ref id="c43"><label>[43]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>F. H.</given-names> <surname>Verbrugge</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Guazzi</surname></string-name>, <string-name><given-names>J. M.</given-names> <surname>Testani</surname></string-name>, <string-name><given-names>B. A.</given-names> <surname>Borlaug</surname></string-name></person-group>, <source>Circulation</source> <year>2020</year>, <volume>142</volume>, <fpage>998</fpage>–<lpage>1012</lpage>.</mixed-citation></ref>
<ref id="c44"><label>[44]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>S.</given-names> <surname>Şimşek-Yavuz</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Şensoy</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Kaşıkçıoğlu</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Ceken</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Deniz</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Yavuz</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Koçak</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Midilli</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Eren</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Yekeler</surname></string-name></person-group>, <source>International Journal of Infectious Diseases</source> <year>2015</year>, <volume>30</volume>, <fpage>106</fpage>–<lpage>114</lpage>.</mixed-citation></ref>
<ref id="c45"><label>[45]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>R. J.</given-names> <surname>Mills</surname></string-name>, <string-name><given-names>D. M.</given-names> <surname>Titmarsh</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Koenig</surname></string-name>, <string-name><given-names>B. L.</given-names> <surname>Parker</surname></string-name>, <string-name><given-names>J. G.</given-names> <surname>Ryall</surname></string-name>, <string-name><given-names>G. A.</given-names> <surname>Quaife-Ryan</surname></string-name>, <string-name><given-names>H. K.</given-names> <surname>Voges</surname></string-name>, <string-name><given-names>M. P.</given-names> <surname>Hodson</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Ferguson</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Drowley</surname></string-name></person-group>, <source>Proceedings of the National Academy of Sciences</source> <year>2017</year>, <volume>114</volume>, <fpage>E8372</fpage>–<lpage>E8381</lpage>.</mixed-citation></ref>
<ref id="c46a"><label>[46a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>T. D.</given-names> <surname>Horvath</surname></string-name>, <string-name><given-names>S. J.</given-names> <surname>Haidacher</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>Engevik</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Luck</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Ruan</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Ihekweazu</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Bajaj</surname></string-name>, <string-name><given-names>K. M.</given-names> <surname>Hoch</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Oezguen</surname></string-name>, <string-name><given-names>J. K.</given-names> <surname>Spinler</surname></string-name></person-group>, <source>Nature Protocols</source> <year>2023</year>, <volume>18</volume>, <fpage>490</fpage>–<lpage>529</lpage>;</mixed-citation></ref>
<ref id="c46b"><label>[46b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>K.</given-names> <surname>Sharma</surname></string-name>, <string-name><given-names>V. V.</given-names> <surname>Thacker</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Dhar</surname></string-name>, <string-name><given-names>M. C.</given-names> <surname>Cabrer</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Dubois</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Signorino-Gelo</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Mullenders</surname></string-name>, <string-name><given-names>G. W.</given-names> <surname>Knott</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Clevers</surname></string-name>, <string-name><given-names>J. D.</given-names> <surname>McKinney</surname></string-name></person-group>, <source>Cell Reports</source> <year>2021</year>, <volume>36</volume>.</mixed-citation></ref>
<ref id="c47a"><label>[47a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A.</given-names> <surname>Boquet-Pujadas</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Feaugas</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Petracchini</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Grassart</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Mary</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Manich</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Gobaa</surname></string-name>, <string-name><given-names>J.-C.</given-names> <surname>Olivo-Marin</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Sauvonnet</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Labruyère</surname></string-name></person-group>, <source>Science Advances</source> <year>2022</year>, <volume>8</volume>, <fpage>eabo5767</fpage>;</mixed-citation></ref>
<ref id="c47b"><label>[47b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>A.</given-names> <surname>Grassart</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Malardé</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Gobaa</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Sartori-Rupp</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Kerns</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Karalis</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Marteyn</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Sansonetti</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Sauvonnet</surname></string-name></person-group>, <source>Cell host &amp; microbe</source> <year>2019</year>, <volume>26</volume>, <fpage>435</fpage>–<lpage>444.e434</lpage>.</mixed-citation></ref>
<ref id="c48a"><label>[48a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>S.</given-names> <surname>Göktepe</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Kuhl</surname></string-name></person-group>, <source>International journal for numerical methods in engineering</source> <year>2009</year>, <volume>79</volume>, <fpage>156</fpage>–<lpage>178</lpage>;</mixed-citation></ref>
<ref id="c48b"><label>[48b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>M.</given-names> <surname>Zuin</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Rigatelli</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Faggian</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Roncon</surname></string-name></person-group>, <source>JACC: Cardiovascular Interventions</source> <year>2016</year>, <volume>9</volume>, <fpage>507</fpage>–<lpage>508</lpage>.</mixed-citation></ref>
<ref id="c49a"><label>[49a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>G.</given-names> <surname>Nadji</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Remadi</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Coviaux</surname></string-name>, <string-name><given-names>A. A.</given-names> <surname>Mirode</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Brahim</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Enriquez-Sarano</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Tribouilloy</surname></string-name></person-group>, <source>Heart</source> <year>2005</year>, <volume>91</volume>, <fpage>932</fpage>–<lpage>937</lpage>;</mixed-citation></ref>
<ref id="c49b"><label>[49b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>Y. Q.</given-names> <surname>Xiong</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Willard</surname></string-name>, <string-name><given-names>M. R.</given-names> <surname>Yeaman</surname></string-name>, <string-name><given-names>A. L.</given-names> <surname>Cheung</surname></string-name>, <string-name><given-names>A. S.</given-names> <surname>Bayer</surname></string-name></person-group>, <source>The Journal of infectious diseases</source> <year>2006</year>, <volume>194</volume>, <fpage>1267</fpage>–<lpage>1275</lpage>.</mixed-citation></ref>
<ref id="c50a"><label>[50a]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>S.</given-names> <surname>Frantz</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Nahrendorf</surname></string-name></person-group>, <source>Cardiovascular research</source> <year>2014</year>, <volume>102</volume>, <fpage>240</fpage>–<lpage>248</lpage>;</mixed-citation></ref>
<ref id="c50b"><label>[50b]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>N. R.</given-names> <surname>Wong</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Mohan</surname></string-name>, <string-name><given-names>B. J.</given-names> <surname>Kopecky</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Guo</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Du</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Leid</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Feng</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Lokshina</surname></string-name>, <string-name><given-names>O.</given-names> <surname>Dmytrenko</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Luehmann</surname></string-name></person-group>, <source>Immunity</source> <year>2021</year>, <volume>54</volume>, <fpage>2072</fpage>-<lpage>2088.e2077</lpage>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.106822.1.sa2</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Gurkar</surname>
<given-names>Aditi U</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of Pittsburgh</institution>
</institution-wrap>
<city>Pittsburgh</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Important</kwd>
</kwd-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Incomplete</kwd>
</kwd-group>
</front-stub>
<body>
<p>This manuscript reports <bold>important</bold> findings that have theoretical or practical implications beyond a single subfield. However, despite the combination of numerous analytical tools established and applied in the study, the work has substantial experimental limitations leading to <bold>incomplete</bold> evidence, indicating that the conclusions may be an over-interpretation of the findings.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.106822.1.sa1</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>In the study by Wang et al. entitled &quot;Dissecting organoid-bacteria interaction highlights decreased contractile force as a key factor for heart infection&quot;, a simple cardiac organoid (CO) model was established, by combining a heterologous mixture of patient-specific human induced pluripotent stem cells (hiPSC)-derived cardiomyocytes (CMs) in combination with primary HUVECs (Human Umbilical Vein Endothelial Cells) and human mesenchymal stem cells (MSCs, representing stromal cells). This model was applied for investigating the interplay of COs' bacterial infections in vitro, aiming at revealing pathological mechanisms of bacterial infections of the heart in vivo, which may induce myocarditis and consequently heart failure in affected patients.</p>
<p>Strengths:</p>
<p>The paper is systematic, well written, and easy to follow.</p>
<p>Based on their results, the authors state that: &quot;In this study, by developing quantitative tools for analyzing bacterial-cardiac organoid interactions in a 3D, dynamic, clinically relevant setting, we discovered the significant role of cardiac contractility in preventing bacterial infection.&quot;</p>
<p>In principle, the idea of establishing a simple yet functionally and physiologically relevant in vitro model and relevant analytical tools for enabling the study of complex pathological mechanisms of cardiovascular diseases is intriguing.</p>
<p>Weaknesses:</p>
<p>However, despite the combination of numerous analytical tools established and applied in the study, the work has substantial experimental limitations, indicating that the bold conclusions may represent a misinterpretation or overinterpretation of the findings.</p>
<p>Key limitations and questions:</p>
<p>(1) It seems that iPSCs from only one patient (&quot;dilated cardiomyopathy (DCM) cells were derived from a 47-year-old Asian male with an LMNA gene mutation&quot;) were used in the study. Moreover, it seems that only one iPSC-line/clone from that DCM patient was used and compared to a single control iPSC line from a &quot;healthy donor&quot;. Therefore, despite the different assays and experimental controls used in the study, there is a high risk that the observed phenomena reflect iPSC-line-/ clone-dependent effects, rather than revealing general pathophysiologic mechanisms. Thus, key experiments must be shown by cardiomyocytes/ cardiac organoids derived from additional independent iPSC-lines representing different patients and other non-diseased control lines as well. Moreover, it is established good experimental practice in the iPS cell field to generate and include isogenic iPSC controls i.e. iPSC lines of the same genetic background but with corrections of the hypothesised gene mutation underlying the respective e.g., cardiovascular disease.</p>
<p>(2) In Figure 1 (A) immunohistochemical staining for cardiomyocytes for the cardiac marker Troponin is shown, apparently indicating successful cardiomyogenic differentiation of the applied hiPSC lines. In supplemental Figure S1, a flow cytometry analysis specific to cTnT is shown to reveal the CMs content resulting from the monolayer differentiation of respective iPSC lines. Already, the exemplified plots indicate that the CMs' content/ purity for DCM-CMs was notably lower compared to healthy cardiomyocytes (CM; control). This is an important issue, since the non-CMs (&quot;contaminating bystander cells&quot;) may have a substantial effect on the functional (including contractile) properties of the COs.</p>
<p>Interestingly, based on the method description, it seems that COs were generated from cryopreserved iPSC-CMs and iPSC-DCMs, including intermediate seeding and culture on Matrigel before COs formation. However, it remains unclear whether the CMs FACS analysis, which is apparently: &quot;Representative FACS plots for analysis of the cell types in DCM monolayer culture after 33 days of differentiation&quot; shows a CMs purity relevant to CO formation, or something different.</p>
<p>The lineage phenotype of non-CMs in respective differentiations should also be clarified. Moreover, it should be noted in the results that the CMs content in COs is lower than the 6:2:2 (CM:ECs:MSC) ratio indicated by the authors, since the CMs purity is not 100%, and is particularly reduced in the iPSC-DCMs.</p>
<p>Finally, to investigate the important latter questions of the &quot;real CMs content&quot; in COs, systematic technologies should be applied to quantify the lineage composition in COs (e.g. by IF staining for the 3 lineages plus DAPI, followed by COs clearance, confocal microscopy &quot;3D stags&quot; and automated, ImageJ-based quantitative cell counts for total cell number definition (see e.g. doi: 10.1038/s41596-024-00976-2) per CO, and quantification of respective lineage content as well.</p>
<p>These questions are of key importance since the presence of non-CMs and their phenotype has profound consequences on the cardiac organoid model, its contractile/ biophysical properties, and, in general, on models' sensitivity to bacterial infections as well.</p>
<p>(3) Figure 2: (F) Why is this figure (Confocal Observations) showing only healthy cardiac organoids (HCOs) but not DCM-COs?</p>
<p>The overall quality of these pictures is poor and not informative regarding the structural identity and tissue composition of the COs, which actually is an important topic in the frame of the paper, as the 3D structure and tissue composition - and differences between HCOs and DCM-COs - are of key importance to their contractile properties.</p>
<p>Moreover, the expective overlay of the cardiac markers alpha-actinin and MHC is not obvious from Figure 2F (see also comments on Figure 7, below).</p>
<p>In Figure 2E: COs at later stages/days should be shown, in particular at that stage, which was used for the functional assays i.e., bacteria infections and contraction pattern monitoring.</p>
<p>(4) Figure 7 (A) (B) - In the IF sections, it seems that there is no overlay between the expression of the cardiac marker MHC (seems to be expressed in the centre of COs only) and the cardiac markers alpha-actinin (which seems to be unexpectedly expressed in all cells on the sections) and Troponin (which seems to be vocally expressed on the outside, excluding the area of MHC expression).</p>
<p>(F) Quantification of the mean area of gene expression, e.g., for MHC indicates a larger area after MHC expression; this seems to entirely contradict the IF pictures (in Figures 7 A-D) of MHC expression before and after infection. This contraction is deemed very critical to this reviewer as it may indicate that the IF staining, data analysis, and/or data interpretation in this part of the manuscript is poor, misleading, or simply wrong.</p>
<p>(5) Overall, from the perspective of this reviewer, the CO-derived results do not reflect in a meaningful way the contractile and hydrodynamic conditions in the mouse heart or the human heart. Thus, it seems that the conclusions may rather represent a hypothesised outcome bias.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.106822.1.sa0</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The authors tried deconvoluting, for the first time, the effect of various components of heart contraction on initial bacterial adhesion, which increases the risk of infective endocarditis. The proposed organoid platform might be used to develop and test novel therapeutic agents for infective endocarditis.</p>
<p>Strengths:</p>
<p>(1) Use of a broad range of methods: finite element methods, -omics, particle tracking, animal experiments to investigate the connections between contractility and infective endocarditis.</p>
<p>(2) Detailed procedure and supportive information, which will allow other groups to replicate the results and extend the application of the proposed organoid platform.</p>
<p>(3) Despite the complexity of the work reported, the manuscript is rather readable and understandable by non-specialists.</p>
<p>Weaknesses:</p>
<p>There is a minor issue with some of the vocabulary (e.g., magnificent amount of bacteria).</p>
</body>
</sub-article>
</article>